Respiratory insufficiency

RESPIRATORYINSUFF

respiratory failure: The significant impairment of gas exchange within the lungs resulting in hypoxia, hypercarbia, or both, to the extent that organ tissue perfusion is severely compromised. Causes include chronic obstructive pulmonary disease, asthma, emphysema, acute respiratory distress syndrome, pneumonia, pulmonary edema, pneumothorax, and congestive heart failure. Treatment requires intubation and mechanical ventilation until the time the lungs recover sufficient function. [NCIT:C26872]

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J96.1 Cause of death: ICD-10 — J96.1 2 out of 7 registries used, show all original rules.	3400
4. Check minimum number of events None	3400
5. Include endpoints None	3400
6. Filter based on genotype QC (FinnGen only)	3400

Control definitions (FinnGen only)

Control exclude: ASTHMA_EXCL

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: J96
Name in latin: Insufficientia respiratoria chronica

NAME	RESPIRATORYINSUFF
CONTROL_EXCLUDE	ASTHMA_EXCL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J961
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J961
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Respiratory insufficiency based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3400	1189	2211
Unadjusted period prevalence (%)	0.78	0.41	0.97
Median age at first event (years)	71.65	69.06	73.04

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2993: Matched controls
29848

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

9.8

323.0

872

1196

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

7.6

323.0

870

1531

XG466

NOMESCO Finland

Sleep oxymetry

59.7

323.0

700

152

WX725

NOMESCO Finland

Noninvasive ventilation

24.9

323.0

690

355

J18.9

ICD-10 Finland

Pneumonia, unspecified

98.1

323.0

1908

524

I50.9

ICD-10 Finland

Heart failure, unspecified

9.4

323.0

1309

2284

R03BA05

ATC

fluticasone; inhalant

8.6

323.0

817

1251

J01MA14

ATC

moxifloxacin; systemic

15.5

323.0

572

449

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

3620.1

323.0

335

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

13.8

323.0

604

536

J96.1

ICD-10 Finland

Chronic respiratory failure

4503599627370496.0

323.0

2992

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

187.0

323.0

829

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

714.4

323.0

1134

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

274.4

323.0

891

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

35.3

323.0

1526

853

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

313.8

323.0

384

XG410

NOMESCO Finland

Flow-volume spirometry

39.8

323.0

421

122

R03AK07

ATC

formoterol and budesonide; inhalant

8.5

323.0

802

1231

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

26.3

323.0

713

350

UGC12

NOMESCO Finland

Flexible bronchoscopy

39.2

323.0

713

236

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

8.0

323.0

1077

1967

R03DA04

ATC

theophylline; systemic, rectal

34.4

323.0

760

292

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

33.1

323.0

501

180

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

932.4

323.0

869

R03AK06

ATC

salmeterol and fluticasone; inhalant

34.6

323.0

1358

698

H02AB06

ATC

prednisolone; systemic

11.2

323.0

2263

6460

R03AC02

ATC

salbutamol; inhalant

11.2

323.0

2213

6011

R03AC12

ATC

salmeterol; inhalant

40.3

323.0

446

129

R03BB04

ATC

tiotropium bromide; inhalant

79.1

323.0

1476

362

J45.9

ICD-10 Finland

Asthma, unspecified

29.2

323.0

884

422

C03CA01

ATC

furosemide; systemic

9.8

323.0

2166

6279

R5140

NOMESCO Finland

Monitoring the use of the aid

12.0

323.0

981

1165

R03BB01

ATC

ipratropium bromide; inhalant

21.5

323.0

494

272

R06.0

ICD-10 Finland

Dyspnoea

9.8

323.0

1535

2906

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

17.3

323.0

713

529

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

223.5

323.0

1747

186

J96.0

ICD-10 Finland

Acute respiratory failure

+∞

323.0

318

J45.1

ICD-10 Finland

Nonallergic asthma

146.3

323.0

373

R95

ICPC

Chron obstructive pulmonary disease

52.5

320.3

386

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

323.7

318.1

318

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

43.5

313.5

392

103

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

140.1

308.1

326

I50.0

ICD-10 Finland

Congestive heart failure

8.5

303.6

734

1100

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.2

293.8

1743

7399

G47.3

ICD-10 Finland

Sleep apnoea

5.5

281.2

999

2495

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

908.1

259.0

251

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

+∞

258.9

245

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

3.9

251.8

1566

6607

J01MA12

ATC

levofloxacin; systemic

5.1

247.2

932

2433

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

8.3

246.7

595

864

J45.0

ICD-10 Finland

Predominantly allergic asthma

56.0

243.4

290

J43.9

ICD-10 Finland

Emphysema, unspecified

418.2

235.9

234

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.8

231.4

916

2493

R03BA01

ATC

beclometasone; inhalant

7.4

230.8

604

986

R03BA02

ATC

budesonide; inhalant

6.6

225.0

647

1202

R02

ICPC

Shortness of breath/dyspnoea

6.6

222.6

633

1157

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

38.6

214.4

275

R03AC13

ATC

formoterol; inhalant

22.0

214.1

320

161

H02AB07

ATC

prednisone; oral

5.6

213.3

713

1590

J45.8

ICD-10 Finland

Mixed asthma

179.2

208.6

217

J01AA02

ATC

doxycycline; systemic

3.7

202.9

2396

15534

J96.9

ICD-10 Finland

Respiratory failure, unspecified

702.2

202.6

198

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

354.2

201.0

201

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

352.3

199.9

200

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

35.1

199.1

261

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

37.0

194.7

252

C03DA01

ATC

spironolactone; oral

5.1

193.8

700

1686

R03DC03

ATC

montelukast; oral

7.2

187.3

492

791

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

38.8

182.8

234

TGC00

NOMESCO Finland

Bronchial lavation

85.5

178.7

200

C07AB07

ATC

bisoprolol; oral

3.0

176.8

1870

10609

R28

ICPC

Limited function/disability (R)

49.3

174.0

212

WX722

NOMESCO Finland

PEEP

10.3

172.7

358

388

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

10.6

159.6

325

339

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

55.4

157.6

188

XG460

NOMESCO Finland

Short time oxymetry

24.0

155.9

226

101

348

Kela drug reimbursment

Roflumilast

+∞

152.2

145

J46

ICD-10 Finland

Status asthmaticus

92.2

149.7

166

J01FA06

ATC

roxithromycin; oral

2.9

149.1

1241

5796

WX721

NOMESCO Finland

Oxygen concentrator therapy

1532.2

149.0

144

R03AC03

ATC

terbutaline; inhalant

5.4

145.9

482

1022

H02AB04

ATC

methylprednisolone; systemic

4.7

144.4

557

1397

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

+∞

139.5

133

A02BC02

ATC

pantoprazole; systemic

2.7

138.6

1963

12419

J47

ICD-10 Finland

Bronchiectasis

1404.2

138.5

134

E66.01

ICD-10 Finland

Obesity due to excess calories

8.2

136.6

324

437

R03AK08

ATC

formoterol and beclometasone; inhalant

34.4

134.0

176

GD1AD

NOMESCO Finland

Thorax CT examination

12.3

133.3

250

219

R03DX07

ATC

roflumilast; oral

+∞

132.1

126

N02AA05

ATC

oxycodone; systemic

3.6

130.5

699

2339

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.8

129.5

1164

5574

A28

ICPC

Limited function/disability NOS

3.3

128.7

795

2962

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

116.5

123.9

134

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

218.4

122.5

126

WX892

NOMESCO Finland

Monitored bed care

5.5

122.1

393

799

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.4

119.7

486

1265

G12.2

ICD-10 Finland

Motor neuron disease

43.9

118.1

147

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

6.4

117.8

333

575

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

16.2

116.5

193

126

R03AC18

ATC

indacaterol; inhalant

95.2

115.9

128

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

+∞

113.1

108

E66.00

ICD-10 Finland

Metabolic syndrome

7.3

111.4

283

420

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.9

110.1

850

3627

XF400

NOMESCO Finland

ECG with 12 standard connections

3.1

109.2

711

2707

R04.2

ICD-10 Finland

Haemoptysis

11.6

108.6

209

192

E66.8

ICD-10 Finland

Other obesity

9.8

108.0

228

250

TPH04

NOMESCO Finland

Cathetrisation of vein

3.0

107.9

765

3084

Z2446

NOMESCO Finland

Social worker

6.2

107.5

308

539

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

24.7

105.5

151

A46

ICD-10 Finland

Erysipelas

3.3

104.3

608

2130

J01CA04

ATC

amoxicillin; systemic

2.4

99.5

2122

15178

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

10.8

99.2

198

195

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.2

99.0

622

2292

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.9

98.7

736

3040

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

+∞

98.3

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

59.5

97.7

115

B01AA03

ATC

warfarin; systemic

2.5

96.9

969

4748

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

56.7

96.9

115

Z51.5

ICD-10 Finland

Palliative care

4.7

96.1

354

826

E66.9

ICD-10 Finland

Obesity, unspecified

11.9

95.4

181

161

SPAT1262

SPAT

Handing over of treatment supplies

2.8

94.4

752

3224

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

7.3

93.5

236

345

RK320

NOMESCO Finland

22.5

91.1

134

N02AX02

ATC

tramadol; systemic, rectal

2.2

89.4

1304

7647

J45

ICD-10 Finland

Asthma

6.6

88.8

242

394

A06AD11

ATC

lactulose; oral

2.8

88.3

655

2673

R06.2

ICD-10 Finland

Wheezing

10.9

87.5

173

167

XG405

NOMESCO Finland

Education on PEF monitoring

57.8

85.5

101

TPH07

NOMESCO Finland

Cathetrisation of artery

3.4

84.7

453

1468

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

220.5

83.7

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

+∞

83.6

J37.0

ICD-10 Finland

Chronic laryngitis

50.4

81.0

RK110

NOMESCO Finland

25.6

80.7

114

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.3

80.3

924

4777

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.1

79.9

515

1902

Z3229

NOMESCO Finland

Other healthcare associate professional

3.6

79.9

399

1221

L28

ICPC

Limited function/disability (L)

2.7

79.4

655

2828

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.3

79.1

916

4741

Z3226

NOMESCO Finland

Physiotherapist

2.7

79.1

620

2595

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

15.4

79.0

133

I50

ICD-10 Finland

Heart failure

6.3

78.9

222

376

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

141.7

78.3

J01FF01

ATC

clindamycin; systemic

2.4

76.7

800

3921

R96

ICPC

Asthma

6.0

75.7

220

388

XG467

NOMESCO Finland

Nocturnal CO2 monitoring

380.5

75.0

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

38.7

73.8

ZXD05

NOMESCO Finland

Urgent procedure

2.2

73.5

951

5155

A07AA02

ATC

nystatin; oral

4.7

72.8

264

600

J01DB01

ATC

cefalexin; oral

2.1

72.7

2160

16500

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

252.0

72.6

R03BA08

ATC

ciclesonide; inhalant

6.1

72.5

207

357

N05CF01

ATC

zopiclone; oral

2.1

71.8

1046

5967

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

33.3

71.4

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

89.9

71.2

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.1

70.8

436

1551

I50.1

ICD-10 Finland

Left ventricular failure

4.4

70.4

276

678

SPAT1254

SPAT

Administration of medicine

2.7

70.1

567

2400

ZXE40

NOMESCO Finland

More than seven and less than nine hours

8.1

70.0

164

213

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.2

69.9

972

5415

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.0

69.3

442

1610

R4110

NOMESCO Finland

Physiotherapy

2.3

69.2

809

4157

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

4.3

68.9

275

687

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

348.9

68.8

Z3231

NOMESCO Finland

Registered nurse

2.2

68.7

872

4656

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

12.1

68.5

128

110

B90.9

ICD-10 Finland

Sequelae of respiratory and unspecified tuberculosis

+∞

67.9

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.3

67.3

216

429

WX730

NOMESCO Finland

Conventional respirator

12.0

67.2

126

109

R50.9

ICD-10 Finland

Fever, unspecified

3.0

66.1

417

1505

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

120.8

66.0

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

65.8

J98.6

ICD-10 Finland

Disorders of diaphragm

+∞

65.8

N03AX16

ATC

pregabalin; oral

2.4

65.0

655

3113

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.3

64.8

752

3835

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.8

64.5

296

837

J94.8

ICD-10 Finland

Other specified pleural conditions

224.1

64.3

J01DA01

ATC

[U] cefalexin; systemic

1.9

64.1

1719

12291

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

4.6

63.9

234

536

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

11.1

63.7

124

116

TDM10

NOMESCO Finland

Puncture of maxillary antrum

63.0

63.6

R03BB02

ATC

oxitropium bromide; inhalant

34.0

63.4

C01AA05

ATC

digoxin; systemic

2.8

63.4

458

1801

M04AA01

ATC

allopurinol; systemic

2.5

62.9

572

2570

GX2C5

NOMESCO Finland

Short-lasting oximetry

+∞

62.6

R03DC01

ATC

zafirlukast; oral

23.7

62.5

284

Kela drug reimbursment

Nintedanib and pirfenidone

+∞

61.6

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

+∞

61.6

R03AK11

ATC

formoterol and fluticasone; inhalant

19.7

61.5

R81

ICPC

Pneumonia

9.9

61.5

127

133

A02BC03

ATC

lansoprazole; oral

2.1

61.5

875

4868

Z01.8

ICD-10 Finland

Other specified special examinations

2.4

61.5

622

2952

M05BA04

ATC

alendronic acid; oral

3.3

61.5

344

1138

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

22.0

61.1

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

56.5

60.9

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

18.9

60.7

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.5

60.6

530

2325

S97

ICPC

Chronic ulcer skin

4.0

60.2

256

676

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.6

60.2

498

2118

R60.0

ICD-10 Finland

Localized oedema

2.8

59.9

421

1623

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.7

59.8

449

1804

GX2D5

NOMESCO Finland

Sleep oximetry

59.5

59.7

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.0

59.6

376

1350

TKC20

NOMESCO Finland

Catheterisation of bladder

3.2

58.8

347

1190

WX872

NOMESCO Finland

Intensive care

4.5

58.7

223

529

C01DA14

ATC

isosorbide mononitrate; oral

2.2

58.0

755

4023

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

+∞

57.4

A02BC01

ATC

omeprazole; systemic

2.1

57.0

855

4836

ZX120

NOMESCO Finland

Intravenous

3.2

56.7

323

1079

J98.1

ICD-10 Finland

Pulmonary collapse

556.4

55.7

356

Kela drug reimbursment

Nintedanib and pirfenidone

+∞

55.3

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

8.3

55.0

126

158

Z94.2

ICD-10 Finland

Lung transplant status

546.0

54.7

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

+∞

54.3

GDG10

NOMESCO Finland

Bilateral transplantation of lung

+∞

54.3

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.5

54.0

271

822

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

22.8

53.6

GD2SN

NOMESCO Finland

Lung ventilation SPECT

28.6

53.6

N06AX11

ATC

mirtazapine; oral

2.1

53.5

806

4545

J42

ICD-10 Finland

Unspecified chronic bronchitis

29.4

53.2

N06AB04

ATC

citalopram; systemic

2.3

52.7

578

2830

L04AA06

ATC

mycophenolic acid; systemic

13.0

52.5

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

52.2

R05CB01

ATC

acetylcysteine; inhalant, oral

9.6

52.1

109

117

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

84.3

52.0

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

24.8

51.6

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.3

51.5

566

2771

SPAT1060

SPAT

Administration of oxygen

34.1

51.4

N05AA02

ATC

levomepromazine; systemic

4.9

51.3

176

375

RS221

NOMESCO Finland

13.6

51.2

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.2

50.7

291

974

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

11.1

50.6

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

4.3

50.3

197

481

J15.8

ICD-10 Finland

Other bacterial pneumonia

258.8

50.2

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.2

49.7

289

978

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

10.8

49.5

J43.8

ICD-10 Finland

Other emphysema

494.3

49.5

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

4.7

49.4

176

391

J01FA10

ATC

azithromycin; systemic

1.8

49.1

1198

8004

R05DA20

ATC

opium alkaloids and derivatives - combinations

2.1

49.1

686

3728

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

91.4

48.9

A41.9

ICD-10 Finland

Sepsis, unspecified

4.8

48.7

170

369

R4190

NOMESCO Finland

Nutritional therapy

6.5

48.5

130

206

GD1UN

NOMESCO Finland

Lung circulation SPECT

30.1

48.4

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

12.0

48.4

JDB10

NOMESCO Finland

Percutaneous gastrostomy

10.7

48.3

R03BB06

ATC

glycopyrronium bromide; inhalant

69.6

48.1

J92.9

ICD-10 Finland

Pleural plaque without asbestos

248.1

48.1

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

47.9

874

5263

J01FA15

ATC

telithromycin; oral

3.4

47.0

249

786

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

46.9

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.9

46.9

912

5614

A10AE04

ATC

insulin glargine; parenteral

2.7

46.6

339

1325

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

6.9

46.5

120

180

R13

ICD-10 Finland

Dysphagia

3.5

46.2

230

691

XF600

NOMESCO Finland

Bloodpressure measurement

3.4

46.2

243

763

N05BA04

ATC

oxazepam; oral

2.0

46.1

672

3706

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

4.1

45.9

187

473

J01FA09

ATC

clarithromycin; systemic

2.0

45.8

677

3748

J34.2

ICD-10 Finland

Deviated nasal septum

41.3

45.7

A01AB09

ATC

miconazole; local oral

3.0

45.6

286

1017

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.2

45.5

551

2804

SPAT1255

SPAT

Intravenous administration of medicine

3.4

45.5

235

727

N02AA01

ATC

morphine; systemic, rectal

7.2

45.4

113

161

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

4.3

45.0

174

419

TGA30

NOMESCO Finland

Thoracocentesis

158.6

44.9

N02BE01

ATC

paracetamol; systemic, rectal

1.8

44.7

2284

19006

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.4

44.6

432

1976

J86.9

ICD-10 Finland

Pyothorax without fistula

442.7

44.3

WX781

NOMESCO Finland

Remote monitoring, noninvasive ventilation

442.7

44.3

J01MA02

ATC

ciprofloxacin; systemic

1.8

43.8

1127

7576

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

43.8

RK250

NOMESCO Finland

32.1

43.2

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.8

43.1

194

536

WX882

NOMESCO Finland

High dependency care

5.5

43.0

131

244

L04AX01

ATC

azathioprine; systemic

4.9

42.8

147

314

A12BA01

ATC

potassium chloride; oral

3.2

42.7

243

807

R03BB07

ATC

umeclidinium bromide; inhalant

41.3

42.5

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.5

42.5

213

643

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.4

42.2

384

1698

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.2

41.8

506

2566

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.9

41.8

749

4442

N05BA01

ATC

diazepam; systemic, rectal

2.4

41.8

404

1841

A10BA02

ATC

metformin; oral

1.8

41.7

941

6043

ZXE00

NOMESCO Finland

One hour or less

1.8

41.6

1051

6999

SPAT1229

SPAT

Assessment of need for aid

2.7

41.5

312

1239

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.1

41.4

251

869

R06AE07

ATC

cetirizine; oral

1.8

41.2

927

5938

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

6.5

41.2

111

177

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.2

41.2

238

796

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.3

41.0

423

1989

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

41.0

857

5360

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

4.1

40.7

168

430

ZX108

NOMESCO Finland

Inhalation

33.6

40.7

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

40.7

N07XX02

ATC

riluzole; oral

39.8

40.6

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

40.4

1098

7456

R99

ICPC

Respiratory disease other

8.5

40.4

108

SPAT1059

SPAT

Spirometry at the office

4.1

40.3

165

419

UDH02

NOMESCO Finland

Rhinopharyngoscopy

5.1

40.1

132

269

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

4.8

40.0

138

296

EBA15

NOMESCO Finland

Extraction of large number of teeth

4.3

40.0

153

365

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

89.1

39.8

D86.0

ICD-10 Finland

Sarcoidosis of lung

+∞

39.6

L04AX05

ATC

pirfenidone; oral

+∞

39.6

J43.2

ICD-10 Finland

Centrilobular emphysema

+∞

39.6

SPAT1263

SPAT

Sampling

1.7

39.5

1095

7466

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.7

39.5

1145

7913

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.9

39.2

685

4009

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.2

39.1

222

735

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.9

38.2

110

192

R03AC19

ATC

olodaterol; inhalant

63.5

38.1

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.7

37.9

279

1094

N05CD07

ATC

temazepam; oral

2.2

37.9

455

2289

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

196.8

37.8

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

37.4

37.8

R05FB02

ATC

cough suppressants and expectorants

1.7

37.5

1025

6933

J31.0

ICD-10 Finland

Chronic rhinitis

6.2

37.2

103

171

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.4

37.1

192

594

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

37.0

858

5513

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

70.6

36.9

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.5

36.7

317

1357

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.9

36.3

155

409

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

7.9

36.2

108

I27.0

ICD-10 Finland

Primary pulmonary hypertension

60.6

36.1

A02BA02

ATC

ranitidine; systemic

1.9

35.8

617

3581

RK310

NOMESCO Finland

98.5

35.7

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.7

35.7

259

1006

N07BA03

ATC

varenicline; oral

5.1

35.6

116

234

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

6.8

35.6

139

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

35.5

897

5903

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

35.4

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

53.0

35.4

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

3.2

35.2

198

648

AN1

Coronary angiography

2.1

35.2

441

2257

C09AA05

ATC

ramipril; oral

1.7

35.0

848

5505

T82

ICPC

Obesity

5.7

35.0

103

185

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.8

34.8

241

909

R01AD09

ATC

mometasone; nasal

1.8

34.6

825

5326

N03AE01

ATC

clonazepam; systemic

3.4

34.5

178

549

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.7

34.2

252

987

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.8

34.1

238

903

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

339.9

33.9

N05AH04

ATC

quetiapine; oral

2.2

33.9

360

1709

127

Kela drug reimbursment

Transplant complication

9.3

33.7

E000001

ATC

2.0

33.7

523

2914

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.3

33.5

180

573

Z72.0

ICD-10 Finland

Tobacco use

9.4

33.5

A02BC05

ATC

esomeprazole; systemic

1.7

33.4

957

6508

E0000UV

ATC

1.7

33.3

948

6433

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

56.2

33.2

R04.0

ICD-10 Finland

Epistaxis

2.6

33.0

263

1077

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

9.1

33.0

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.6

32.9

156

451

XG474

NOMESCO Finland

Exhalation nntrogen oxide

18.7

32.6

R53

ICD-10 Finland

Malaise and fatigue

1.9

32.6

530

2999

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

31.0

32.5

J20

ICD-10 Finland

Acute bronchitis

2.8

32.5

227

860

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

5.4

32.4

100

190

49104

ICD-8 Finland

Chronic bronchitis, Cum emphysemate

+∞

32.3

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

6.1

32.3

151

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

20.2

32.1

UDQ12

NOMESCO Finland

Flexible laryngoscopy

4.1

32.1

129

323

WYA20

NOMESCO Finland

Home visit

5.5

31.9

181

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.2

31.8

176

572

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.0

31.7

191

657

T90

ICPC

Diabetes non-insulin dependent

1.8

31.4

706

4450

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

31.3

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

+∞

31.3

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

+∞

31.3

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

15.0

31.3

R33

ICD-10 Finland

Retention of urine

2.2

31.2

349

1694

GBB00

NOMESCO Finland

Tracheostomy

8.5

30.8

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

29.6

30.7

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.3

30.6

299

1359

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

30.2

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

+∞

30.2

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

18.6

30.0

TJD20

NOMESCO Finland

Change of gastrostomy tube

22.9

30.0

J01DA06

ATC

[U] cefuroxime; systemic

2.1

29.9

355

1766

M10.9

ICD-10 Finland

Gout, unspecified

2.6

29.9

237

967

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.6

29.9

141

406

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.4

29.8

266

1156

R03AL05

ATC

formoterol and aclidinium bromide; inhalant

107.5

29.7

WW200

NOMESCO Finland

Immunization

5.2

29.6

185

N05AH03

ATC

olanzapine; systemic

3.7

29.6

135

378

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.6

29.6

232

941

A10AE05

ATC

insulin detemir; parenteral

3.0

29.5

181

631

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

29.5

800

5316

N99

ICPC

Neurological disease other

7.1

29.4

105

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

29.3

1756

14249

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.7

29.3

212

819

L01XE31

ATC

[U] nintedanib; oral

+∞

29.2

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

9.0

29.1

XA421

NOMESCO Finland

Nocturnal polygraphy

31.9

29.0

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

4.2

29.0

114

280

R29

ICPC

Respiratory symptom/complaint other

3.3

28.9

154

487

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

293.8

28.8

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.2

28.5

306

1455

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

28.5

352

1780

L89

ICD-10 Finland

Decubitus ulcer and pressure area

5.2

28.5

176

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.2

28.5

153

487

AA1AD

NOMESCO Finland

CT of head and brain

1.7

28.4

660

4184

F20.9

ICD-10 Finland

Schizophrenia, unspecified

7.6

28.2

R47.1

ICD-10 Finland

Dysarthria and anarthria

7.2

28.2

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

28.1

J84.0

ICD-10 Finland

Alveolar and parietoalveolar conditions

+∞

28.1

L04AD01

ATC

ciclosporin; systemic

7.0

27.9

102

UJF32

NOMESCO Finland

Coloscopy

1.7

27.8

699

4534

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

283.1

27.7

R03BB05

ATC

aclidinium bromide; inhalant

78.1

27.7

RD210

NOMESCO Finland

6.7

27.7

107

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.3

27.7

285

1328

N06AX16

ATC

venlafaxine; oral

2.4

27.4

248

1085

C08DA01

ATC

verapamil; systemic

3.1

27.4

155

510

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

27.4

256

1139

RS230

NOMESCO Finland

23.1

27.3

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

27.1

J93.9

ICD-10 Finland

Pneumothorax, unspecified

+∞

27.1

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

27.1

R01AD08

ATC

fluticasone; nasal

1.8

27.1

491

2872

SPAT1231

SPAT

Assessment of adjustments needed in living environment

4.2

27.1

105

255

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.7

27.0

199

777

N05BA06

ATC

lorazepam; systemic, sublingual

2.9

26.9

172

617

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

26.8

685

4456

J12.8

ICD-10 Finland

Other viral pneumonia

272.5

26.7

WX726

NOMESCO Finland

High-flow oxygen therapy

272.5

26.7

R1250

NOMESCO Finland

Evaluation of functional capability

5.0

26.7

177

49300

ICD-8 Finland

Asthma, bronchiale

5.9

26.6

132

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

5.5

26.6

148

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

140.8

26.6

A10BH01

ATC

sitagliptin; oral

2.1

26.6

310

1528

M81.9

ICD-10 Finland

Osteoporosis, unspecified

3.4

26.6

134

407

N06AA09

ATC

amitriptyline; systemic

2.3

26.5

263

1205

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

26.5

525

3158

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.6

26.4

202

805

K77

ICPC

Heart failure

4.3

26.3

101

243

A04

ICPC

Weakness/tiredness general

2.0

26.2

351

1831

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.3

26.2

137

428

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.4

26.2

132

401

DJD20

NOMESCO Finland

Plastic repair of septum of nose

36.9

26.1

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

5.2

25.8

162

ZXA10

NOMESCO Finland

Bilateral

1.8

25.6

505

3031

E66

ICD-10 Finland

Obesity

4.1

25.6

103

259

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

25.5

273

1294

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

12.2

25.4

N05BA12

ATC

alprazolam; oral

2.3

25.4

248

1126

Z2221

NOMESCO Finland

Medical doctor

1.7

25.4

663

4328

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.6

25.4

373

5999

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.9

25.3

107

281

E87.5

ICD-10 Finland

Hyperkalaemia

5.0

25.3

170

N03AX12

ATC

gabapentin; oral

2.0

25.3

350

1848

WZC30

NOMESCO Finland

Teaching

2.0

25.3

334

1732

UKC02

NOMESCO Finland

Cystoscopy

1.7

25.3

568

3549

RK323

NOMESCO Finland

25.2

H25.1

ICD-10 Finland

Senile nuclear cataract

1.6

25.0

916

6535

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

+∞

25.0

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

25.0

R05FA02

ATC

opium derivatives and expectorants; systemic

1.6

24.9

979

7100

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

8.7

24.9

N06AX21

ATC

duloxetine; oral

2.4

24.9

217

929

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.2

24.9

134

428

N03AG01

ATC

valproic acid; systemic, rectal

3.0

24.9

148

506

XF622

NOMESCO Finland

Measurement of minute volume of heart

19.6

24.7

N19

ICD-10 Finland

Unspecified kidney failure

3.1

24.6

140

464

N06AB10

ATC

escitalopram; oral

2.0

24.5

356

1919

A03

ICPC

Fever

2.2

24.4

275

1334

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.3

24.2

125

387

Z99.1

ICD-10 Finland

Dependence on respirator

+∞

24.0

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

24.0

Z02.4

ICD-10 Finland

Examination for driving licence

0.6

23.9

366

5839

J43.1

ICD-10 Finland

Panlobular emphysema

241.0

23.6

B01AB05

ATC

enoxaparin; parenteral

1.6

23.5

778

5395

N18.8

ICD-10 Finland

Other chronic renal failure

3.5

23.5

114

337

XQ800

NOMESCO Finland

Prick test

3.6

23.4

108

306

J02AC01

ATC

fluconazole; systemic

1.6

23.4

703

4755

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.3

23.3

221

990

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

6.7

23.1

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.7

23.1

629

4142

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.3

23.1

120

374

J33.0

ICD-10 Finland

Polyp of nasal cavity

22.2

23.0

J93.0

ICD-10 Finland

Spontaneous tension pneumothorax

+∞

22.9

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

+∞

22.9

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

5.4

22.9

129

JN4BD

NOMESCO Finland

Extensive body CT

2.0

22.8

302

1566

N05AH02

ATC

clozapine; systemic

9.3

22.7

J18

ICD-10 Finland

Pneumonia, organism unspecified

16.5

22.7

J80

ICD-10 Finland

Adult respiratory distress syndrome

230.9

22.6

R60.9

ICD-10 Finland

Oedema, unspecified

2.8

22.6

149

543

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

26.0

22.6

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

22.6

416

2436

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.0

22.5

134

458

N05AX12

ATC

aripiprazole; systemic

5.0

22.4

149

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

22.3

742

5142

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.3

22.3

206

910

R03DA05

ATC

aminophylline; systemic, rectal

8.5

22.0

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.7

22.0

152

573

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.2

21.9

224

1038

XV5WT

NOMESCO Finland

+∞

21.9

D75.1

ICD-10 Finland

Secondary polycythaemia

10.1

21.7

N06AB06

ATC

sertraline; oral

2.3

21.7

202

894

N05AF03

ATC

chlorprothixene; systemic

4.4

21.7

186

A10BB12

ATC

glimepiride; oral

2.0

21.5

288

1502

R4130

NOMESCO Finland

Speech therapy

4.3

21.5

188

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

4.4

21.4

179

TK800

NOMESCO Finland

Hemodialysis

4.6

21.3

162

R06.5

ICD-10 Finland

Mouth breathing

2.4

21.2

182

774

SPAT1251

SPAT

Organisation of medication

2.9

21.1

129

450

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

20.9

205

933

GAC00

NOMESCO Finland

Biopsy of pleura

+∞

20.8

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

+∞

20.8

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

+∞

20.8

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

20.7

257

1297

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.9

20.7

229

SPAT1216

SPAT

Assessment of functional ability

1.7

20.6

473

2956

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

20.6

903

6650

J01CE08

ATC

benzathine benzylpenicillin; parenteral

6.4

20.6

A08

ICPC

Swelling

2.9

20.5

129

459

M05BA07

ATC

risedronic acid; oral

3.2

20.4

110

353

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

20.3

647

4418

SPAT1234

SPAT

Support of social functional capacity

2.4

20.2

176

754

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

6.1

20.2

K07

ICPC

Swollen ankles/oedema

2.7

20.0

142

541

SPAT1257

SPAT

Teaching of medicine inhalation technique

3.6

20.0

261

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

18.9

19.9

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

20.8

19.9

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

19.8

596

4008

A15.0

ICD-10 Finland

Tuberculosis of lung, confirmed by sputum microscopy with or without culture

+∞

19.8

132

Kela drug reimbursment

Sarcoidosis

+∞

19.8

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

3.5

19.6

266

J81

ICD-10 Finland

Pulmonary oedema

105.4

19.5

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

105.4

19.5

C02KX04

ATC

macitentan; oral

105.4

19.5

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

19.4

474

3014

N05AX08

ATC

risperidone; systemic

2.1

19.4

223

1088

R05

ICPC

Cough

1.7

19.3

426

2629

M03BX01

ATC

baclofen; systemic

5.3

19.3

113

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.5

19.2

156

646

N05AC02

ATC

thioridazine; oral

4.5

19.1

153

RS220

NOMESCO Finland

6.0

19.1

XA420

NOMESCO Finland

Extensive sleep examination

7.4

19.1

E000003

ATC

2.9

19.0

117

411

E66.0

ICD-10 Finland

Obesity due to excess calories

6.2

19.0

A02BA04

ATC

nizatidine; systemic

2.0

18.9

242

1237

I25.2

ICD-10 Finland

Old myocardial infarction

1.9

18.9

280

1514

ZY010

NOMESCO Finland

Hospital outpatient

3.2

18.7

308

J94.2

ICD-10 Finland

Haemothorax

+∞

18.7

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

18.7

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

18.7

354

2083

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.4

18.7

276

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

27.9

18.7

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.1

18.7

229

1150

A10BJ02

ATC

liraglutide; parenteral

4.3

18.6

162

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.3

18.6

167

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.8

18.5

118

424

JN3AD

NOMESCO Finland

Abdominal CT examination

2.2

18.5

198

937

I26

ICD-10 Finland

Pulmonary embolism

6.8

18.4

A98

ICPC

Health maint/preventive medicine

0.7

18.4

2006

22285

SPAT1172

SPAT

Guidance concerning hydration

3.2

18.4

318

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.4

18.4

161

691

RS121

NOMESCO Finland

10.7

18.4

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.0

18.3

230

1166

A01AB04

ATC

amphotericin B; local oral

2.6

18.2

139

555

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

18.2

780

5685

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

25.1

18.2

R05CB03

ATC

carbocisteine; oral

3.6

18.2

230

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

4.8

18.1

130

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

19.4

18.1

TQW11

NOMESCO Finland

Vacuum treatment of wound

4.6

18.1

139

SPAT1240

SPAT

Therapeutic discussion

2.3

18.1

168

744

N05AA01

ATC

chlorpromazine; systemic, rectal

6.1

18.1

J38.3

ICD-10 Finland

Other diseases of vocal cords

52.7

17.9

XX4BW

NOMESCO Finland

33.0

17.9

G04BE03

ATC

sildenafil; oral

4.0

17.9

178

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

5.6

17.9

F29

ICD-10 Finland

Unspecified nonorganic psychosis

4.2

17.9

164

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

10.7

17.9

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.3

17.8

172

777

H02AB09

ATC

hydrocortisone; systemic

4.8

17.8

124

N03AX09

ATC

lamotrigine; oral

3.6

17.8

224

N06AA12

ATC

doxepin; systemic

2.5

17.7

148

620

8000/3-C34.1

ICD-O-3

Neoplasm, malignant of upper lobe, lung

+∞

17.7

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

17.7

R52.2

ICD-10 Finland

Other chronic pain

3.4

17.6

252

SPAT1211

SPAT

Application of soft bandage

2.0

17.6

236

1229

205

Kela drug reimbursment

Chronic hypertension

1.4

17.6

993

7649

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.4

17.5

J01DC02

ATC

cefuroxime; systemic

2.9

17.5

111

397

D07AC01

ATC

betamethasone; topical

1.5

17.5

805

5949

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

17.4

381

2343

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

4.8

17.4

123

I42.0

ICD-10 Finland

Dilated cardiomyopathy

3.1

17.3

304

P01AB01

ATC

metronidazole; oral, rectal

1.5

17.3

804

5949

160

Kela drug reimbursment

exenatide

4.3

17.2

151

RS122

NOMESCO Finland

42.1

17.2

DHB20

NOMESCO Finland

Polypectomy of internal nose

42.1

17.2

I95.9

ICD-10 Finland

Hypotension, unspecified

4.7

17.2

124

R04

ICPC

Breathing problem other

3.3

17.2

262

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

5.8

17.2

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

16.0

17.0

Z43.0

ICD-10 Finland

Attention to tracheostomy

50.1

17.0

SPAT1167

SPAT

Insertion of urinary catheter

2.5

16.9

134

547

I20.00

ICD-10 Finland

Unstable angina

2.6

16.9

125

493

N04AA02

ATC

biperiden; systemic

4.5

16.9

136

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

5.0

16.8

110

JN4AD

NOMESCO Finland

Body CT examination

2.1

16.8

202

1004

N30.0

ICD-10 Finland

Acute cystitis

1.8

16.8

301

1739

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.2

16.8

179

845

GDC00

NOMESCO Finland

Lobectomy of lung

63.5

16.7

J18.8

ICD-10 Finland

Other pneumonia, organism unspecified

63.5

16.7

N05AB03

ATC

perphenazine; systemic, rectal

3.0

16.7

323

N30.9

ICD-10 Finland

Cystitis, unspecified

2.5

16.7

136

565

4919X

ICD-9 Finland

Chronic bronchitis, Unspecified chronic bronchitis

+∞

16.7

J94.1

ICD-10 Finland

Fibrothorax

+∞

16.7

A15.1

ICD-10 Finland

Tuberculosis of lung, confirmed by culture only

+∞

16.7

J69.1

ICD-10 Finland

Pneumonitis due to oils and essences

+∞

16.7

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

16.7

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

3.3

16.6

269

SPAT1281

SPAT

Other administrative function

2.0

16.6

206

1040

E88.0

ICD-10 Finland

Disorders of plasma-protein metabolism, not elsewhere classified

170.3

16.5

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.6

16.5

125

499

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.1

16.5

191

937

G82.2

ICD-10 Finland

Paraplegia, unspecified

13.4

16.4

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.9

16.4

343

R84

ICPC

Malignant neoplasm bronchus/lung

40.2

16.3

GDA10

NOMESCO Finland

Biopsy of lung

40.2

16.3

R11

ICD-10 Finland

Nausea and vomiting

2.2

16.3

174

825

SPAT1104

SPAT

Monitoring of emergency patient

2.1

16.2

180

865

D21

ICPC

Swallowing problem

5.0

16.2

106

K93

ICPC

Pulmonary embolism

6.8

16.1

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.7

16.1

191

J01EA01

ATC

trimethoprim; systemic

1.5

16.1

597

4196

RS222

NOMESCO Finland

5.0

16.0

103

S76

ICPC

Skin infection other

2.4

16.0

135

571

5AB14

NOMESCO Finland

47.6

16.0

OAB43

SPAT

0.2

16.0

785

R05DA01

ATC

ethylmorphine; oral

2.1

16.0

194

971

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

21.0

15.9

B01AC04

ATC

clopidogrel; oral

1.6

15.9

491

3305

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.2

15.9

163

757

F34.1

ICD-10 Finland

Dysthymia

3.7

15.7

190

N06AB03

ATC

fluoxetine; oral

1.9

15.6

255

1425

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

+∞

15.6

GX1P5

NOMESCO Finland

Nocturnal CO2 monitoring

+∞

15.6

51899

ICD-8 Finland

Bronchiectasis

+∞

15.6

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

+∞

15.6

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

15.6

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

15.6

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

+∞

15.6

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.3

15.6

239

Z93.1

ICD-10 Finland

Gastrostomy status

85.3

15.5

C02KX01

ATC

bosentan; oral

85.3

15.5

J94.9

ICD-10 Finland

Pleural condition, unspecified

160.3

15.5

A16.0

ICD-10 Finland

Tuberculosis of lung, bacteriologically and histologically negative

160.3

15.5

C02KX05

ATC

riociguat; oral

160.3

15.5

K59.09

ICD-10 Finland

Constipation, unspecified

2.2

15.4

165

782

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

15.4

691

5058

R06

ICD-10 Finland

Abnormalities of breathing

10.1

15.4

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

8.9

15.4

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.5

15.4

124

511

E87.6

ICD-10 Finland

Hypokalaemia

2.9

15.3

314

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

15.3

157

729

H26.3

ICD-10 Finland

Drug-induced cataract

12.3

15.3

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

2.5

15.3

117

469

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.9

15.3

160

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

15.3

627

4506

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

15.2

349

2173

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

28.6

15.2

207

Kela drug reimbursment

Chronic arrhythmias

1.6

15.1

457

3057

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.5

15.1

123

511

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

15.1

277

1608

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

23.4

15.1

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.2

15.1

155

721

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.3

15.0

235

R05

ICD-10 Finland

Cough

1.7

15.0

349

2181

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.6

15.0

109

426

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.6

14.9

109

427

G72.9

ICD-10 Finland

Myopathy, unspecified

6.8

14.9

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.8

14.8

343

C08DB01

ATC

diltiazem; oral

1.9

14.8

210

1117

RS123

NOMESCO Finland

31.7

14.8

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

14.7

210

1120

D07XC01

ATC

betamethasone, combinations; topical

1.7

14.7

301

1813

A08AB01

ATC

orlistat; oral

6.8

14.6

J85.1

ICD-10 Finland

Abscess of lung with pneumonia

+∞

14.6

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

+∞

14.6

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

+∞

14.6

XG416

NOMESCO Finland

Measurement of maximal airway pressure

+∞

14.6

J38.1

ICD-10 Finland

Polyp of vocal cord and larynx

+∞

14.6

N06AX03

ATC

mianserin; oral

2.4

14.6

123

522

XF404

NOMESCO Finland

Ambulatory ECG

1.8

14.5

251

1428

WX723

NOMESCO Finland

CPAP therapy

3.3

14.5

230

J01DA08

ATC

[U] cefaclor; oral

2.1

14.5

168

825

R05CB02

ATC

bromhexine; systemic

3.8

14.5

163

XFE00

NOMESCO Finland

Epicardial ultrasonography

2.8

14.4

327

R85

ICPC

Malignant neopl respiratory other

36.1

14.4

SPAT1252

SPAT

Overall medication plan or its review

1.9

14.4

205

1093

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

6.2

14.3

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

5.4

14.3

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

27.2

14.2

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

3.0

14.2

278

1240

FHL

Bronchoscopy

5.4

14.1

R01

ICPC

Pain respiratory system

5.7

14.1

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.7

14.1

162

N05AF05

ATC

zuclopenthixol; systemic

7.0

14.0

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.4

14.0

199

K59.1

ICD-10 Finland

Functional diarrhoea

2.4

14.0

121

517

E000006

ATC

2.1

13.9

166

824

SPAT1301

SPAT

No procedures

1.4

13.9

801

6134

R78

ICPC

Acute bronchitis/bronchiolitis

4.2

13.9

125

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.3

13.9

124

541

R03CC02

ATC

salbutamol; systemic

3.3

13.8

217

R03DA54

ATC

theophylline, combinations excl. psycholeptics; systemic

4.4

13.8

112

K92.1

ICD-10 Finland

Melaena

2.1

13.8

165

823

G82.5

ICD-10 Finland

Tetraplegia, unspecified

23.8

13.8

Z50.1

ICD-10 Finland

Other physical therapy

2.1

13.7

149

713

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

9.1

13.7

N05AD01

ATC

haloperidol; systemic

2.6

13.6

100

393

3AC01

NOMESCO Finland

5.9

13.5

L01EX09

ATC

nintedanib; oral

+∞

13.5

49109

ICD-8 Finland

Chronic bronchitis, Unspecified

+∞

13.5

J93.8

ICD-10 Finland

Other pneumothorax

+∞

13.5

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

13.5

GAC46

NOMESCO Finland

Partial decortication of pleura

+∞

13.5

B01AF02

ATC

apixaban; oral

1.7

13.5

280

1688

A10BH05

ATC

linagliptin; oral

2.1

13.5

154

752

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

3.5

13.5

179

J41.0

ICD-10 Finland

Simple chronic bronchitis

16.2

13.4

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

9.4

13.4

C08CA01

ATC

amlodipine; oral

1.4

13.4

992

7930

I20.09

ICD-10 Finland

Unstable angina

1.9

13.3

185

978

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.6

13.3

393

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

6.2

13.3

I45.9

ICD-10 Finland

Conduction disorder, unspecified

5.9

13.2

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.2

13.2

133

617

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.8

13.1

232

1334

A11CC03

ATC

alfacalcidol; systemic

3.2

13.1

210

A10BX07

ATC

[U] liraglutide; parenteral

4.6

13.0

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

3.1

13.0

233

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.4

13.0

961

7669

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.1

12.9

143

689

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

10.0

12.9

T91.3

ICD-10 Finland

Sequelae of injury of spinal cord

10.0

12.9

B01AB10

ATC

tinzaparin; parenteral

2.0

12.9

171

886

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

6.4

12.9

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

5.0

12.8

A41.8

ICD-10 Finland

Other specified sepsis

3.8

12.8

140

GX1K5

NOMESCO Finland

Diffusion capacity

50.0

12.8

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.9

12.7

274

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.9

12.6

132

RF220

NOMESCO Finland

4.2

12.6

113

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.3

12.6

119

535

R06AX22

ATC

ebastine; oral

1.7

12.6

265

1606

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

3.4

12.6

173

G04CA02

ATC

tamsulosin; oral

1.4

12.6

835

6536

E86

ICD-10 Finland

Volume depletion

3.0

12.6

242

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

12.6

218

3428

Z93.0

ICD-10 Finland

Tracheostomy status

69.9

12.6

L73.2

ICD-10 Finland

Hidradenitis suppurativa

12.3

12.6

R03AC04

ATC

fenoterol; inhalant

12.3

12.6

DMB10

NOMESCO Finland

Radical maxillary antrotomy

+∞

12.5

J91

ICD-10 Finland

Pleural effusion in conditions classified elsewhere

+∞

12.5

J86.00

ICD-10 Finland

Empyema with broncho-pleural fistula

+∞

12.5

J01GB01

ATC

tobramycin; inhalant, parenteral

+∞

12.5

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.3

12.5

118

531

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.7

12.5

316

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.7

12.4

149

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

0.7

12.4

388

5399

N03AF01

ATC

carbamazepine; oral, rectal

2.1

12.4

134

638

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

3.0

12.4

246

R10.0

ICD-10 Finland

Acute abdomen

3.0

12.4

246

C09AA02

ATC

enalapril; systemic

1.4

12.4

615

4565

P28

ICPC

Limited function/disability (P)

7.6

12.3

A02BA03

ATC

famotidine; systemic

2.2

12.3

127

595

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

12.3

214

1223

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

5.9

12.2

Z28

ICPC

Limited function/disability (Z)

9.0

12.2

V03AA01

ATC

3.9

12.2

127

D07AC13

ATC

mometasone; topical

1.4

12.1

637

4780

GAB10

NOMESCO Finland

Antero- or postero-lateral thoracotomy

12.4

12.1

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.1

12.1

A29

ICPC

General symptom/complaint other

1.7

12.1

279

1736

WZA10

NOMESCO Finland

Long statement of health and health related matters

5.3

12.0

P76

ICPC

Depressive disorder

2.6

12.0

347

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

8.2

12.0

D07AB08

ATC

desonide; topical

1.8

12.0

227

1334

R60.1

ICD-10 Finland

Generalized oedema

8.7

12.0

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.8

12.0

134

Z71.8

ICD-10 Finland

Other specified counselling

1.5

11.9

442

3092

M54.5

ICD-10 Finland

Low back pain

1.4

11.9

605

4507

D09AB01

ATC

zinc bandage without supplements; topical

3.3

11.9

176

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.8

11.9

265

E000002

ATC

1.8

11.9

214

1239

J43

ICD-10 Finland

Emphysema

46.7

11.9

TGB20

NOMESCO Finland

Tracheostomy tube replacement

46.7

11.9

WX740

NOMESCO Finland

Nitrogen oxide therapy

46.7

11.9

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.4

11.9

407

R01AD12

ATC

fluticasone furoate; nasal

1.5

11.8

402

2758

SPAT1325

SPAT

Vaccination

1.4

11.8

911

7294

M10.2

ICD-10 Finland

Drug-induced gout

11.7

11.8

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

3.0

11.8

216

S10

ICPC

Boil/carbuncle

2.2

11.8

123

580

P29

ICPC

Psychological sympt/compl other

2.7

11.8

297

N17.8

ICD-10 Finland

Other acute renal failure

4.7

11.8

J36

ICD-10 Finland

Peritonsillar abscess

14.6

11.8

D07AA02

ATC

hydrocortisone; topical

1.7

11.7

271

1690

M79.6

ICD-10 Finland

Pain in limb

1.4

11.7

716

5516

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

11.7

411

2841

K08.3

ICD-10 Finland

Retained dental root

1.9

11.6

167

892

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

11.6

171

922

K92.0

ICD-10 Finland

Haematemesis

2.7

11.6

293

RS142

NOMESCO Finland

30.0

11.6

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.5

11.6

354

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

3.3

11.6

169

5198X

ICD-9 Finland

Other diseases of respiratory system, not elsewhere classified

65.0

11.6

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.8

11.6

206

1186

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.3

11.6

111

502

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.5

11.6

C10AA01

ATC

simvastatin; oral

1.3

11.6

1308

11078

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

22.9

11.5

R05CA10

ATC

expectorants - combinations

3.3

11.5

176

SPAT1260

SPAT

Consultation of another employee

1.5

11.4

403

2783

J98.2

ICD-10 Finland

Interstitial emphysema

+∞

11.4

XG420

NOMESCO Finland

Time-volume spirometry

+∞

11.4

T59.7

ICD-10 Finland

Toxic effect: Carbon dioxide

+∞

11.4

Z08

ICPC

Social welfare problem

5.3

11.4

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

120.1

11.4

0114

NOMESCO Finland

120.1

11.4

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.9

11.4

244

N28

ICPC

Limited function/disability (N)

3.3

11.4

166

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.7

11.4

278

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.3

11.3

172

A06AH03

ATC

naloxegol; oral

4.6

11.3

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

5.0

11.3

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

4.0

11.3

111

R05DB20

ATC

other cough suppressants - combinations

2.1

11.3

124

597

GAA31

NOMESCO Finland

Thoracoscopy

35.0

11.2

W19

ICD-10 Finland

Unspecified fall

1.7

11.2

215

1266

H05AA02

ATC

teriparatide; parenteral

10.5

11.2

318

Kela drug reimbursment

Teriparatide

9.6

11.2

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.1

11.1

128

630

G71.9

ICD-10 Finland

Primary disorder of muscle, unspecified

25.0

11.1

Z94.1

ICD-10 Finland

Heart transplant status

25.0

11.1

DHB50

NOMESCO Finland

Turbinoplasty

25.0

11.1

J01CF05

ATC

flucloxacillin; systemic

2.6

11.1

318

K55.8

ICD-10 Finland

Other vascular disorders of intestine

7.6

11.1

RS340

NOMESCO Finland

12.7

11.1

RS310

NOMESCO Finland

20.0

11.1

N06DX01

ATC

memantine; oral

0.5

11.1

1415

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.4

11.1

390

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.2

11.0

107

488

K59.0

ICD-10 Finland

Constipation

2.0

11.0

138

704

E87.2

ICD-10 Finland

Acidosis

8.5

11.0

D07BC01

ATC

betamethasone and antiseptics; topical

1.6

11.0

273

1734

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

10.0

11.0

I44.0

ICD-10 Finland

Atrioventricular block, first degree

3.1

10.9

188

N07BB01

ATC

disulfiram; oral

2.6

10.9

305

R5599

NOMESCO Finland

Other rehabilitation service

2.7

10.9

266

188

Kela drug reimbursment

Psychosis requiring demanding treatment

7.4

10.9

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

3.9

10.9

115

G71.11

ICD-10 Finland

Dystrophia myotonica [Steinert]

43.3

10.9

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

3.4

10.9

156

U04

ICPC

Incontinence urine

2.0

10.9

130

648

162

Kela drug reimbursment

liraglutide

4.6

10.8

A34

ICPC

General and Unspecified, Blood test

3.9

10.8

111

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.0

10.8

130

652

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.5

10.8

326

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.9

10.8

230

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

10.8

325

2165

M01AH02

ATC

rofecoxib; oral

1.6

10.7

306

2013

R40.2

ICD-10 Finland

Coma, unspecified

4.6

10.7

J01XX08

ATC

linezolid; systemic

9.6

10.7

J11.0

ICD-10 Finland

Influenza with pneumonia, virus not identified

28.0

10.7

UGB02

NOMESCO Finland

Tracheoscopy

28.0

10.7

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

17.8

10.7

Z43.5

ICD-10 Finland

Attention to cystostomy

5.8

10.7

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.0

10.7

206

G71.08

ICD-10 Finland

Other muscular dystrophy

21.5

10.7

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.6

10.6

290

S12

ICPC

Insect bite/sting

0.4

10.6

1169

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

60.0

10.6

GD1FN

NOMESCO Finland

Lung ventilation isotope imaging

60.0

10.6

J38.4

ICD-10 Finland

Oedema of larynx

60.0

10.6

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.0

10.6

141

735

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.4

10.5

1240

N02AC04

ATC

dextropropoxyphene; oral

2.0

10.5

125

622

A10BJ06

ATC

semaglutide; parenteral

2.8

10.5

245

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

3.2

10.5

166

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.5

10.5

311

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

10.5

890

7203

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.0

10.5

125

625

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.2

10.5

109

515

RF120

NOMESCO Finland

4.6

10.4

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

10.4

01107

ICD-8 Finland

Pulmonary tuberculosis, Suspecta

+∞

10.4

J35.2

ICD-10 Finland

Hypertrophy of adenoids

+∞

10.4

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

+∞

10.4

J43.0

ICD-10 Finland

MacLeod syndrome

+∞

10.4

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

+∞

10.4

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

10.4

J99.0*M05.1

ICD-10 Finland

Rheumatoid lung disease

+∞

10.4

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

+∞

10.4

J95.1

ICD-10 Finland

Acute pulmonary insufficiency following thoracic surgery

+∞

10.4

3A006

NOMESCO Finland

+∞

10.4

FB1BC

NOMESCO Finland

Extensive angiography of arteria pulmonalis

110.0

10.4

-50

ICPC

Medication/prescr/renewal

2.1

10.4

115

555

N05BA02

ATC

chlordiazepoxide; systemic

2.8

10.4

224

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

3.3

10.4

157

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

7.7

10.3

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

6.8

10.3

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

16.0

10.3

A07AA09

ATC

vancomycin; oral

4.5

10.3

F61.0

ICD-10 Finland

Mixed personality disorders

4.9

10.3

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

8.2

10.3

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

6.4

10.3

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.1

10.2

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

10.6

10.2

UDM02

NOMESCO Finland

Sinoscopy

6.0

10.2

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

8.8

10.2

5150X

ICD-9 Finland

Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]

18.8

10.2

P99

ICPC

Psychological disorders other

3.6

10.2

127

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.7

10.2

548

7003

GBB13

NOMESCO Finland

Revision of tracheostomy

23.4

10.2

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.4

10.2

340

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.7

10.2

254

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

10.2

202

1202

280

Kela drug reimbursment

Clopidogrel

2.9

10.2

209

A10BH02

ATC

vildagliptin; oral

2.7

10.1

257

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

10.1

164

918

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.5

10.1

134

7931A

ICD-9 Finland

Nonspecific abnormal findings on radiological and other examination of body structure, Lung field

6.9

10.0

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.0

10.0

134

697

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.7

10.0

251

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

3.2

10.0

156

XJC10

NOMESCO Finland

Oesophageal pH monitoring

8.4

10.0

5CM18

NOMESCO Finland

8.4

10.0

F20.5

ICD-10 Finland

Residual schizophrenia

8.4

10.0

R63.4

ICD-10 Finland

Abnormal weight loss

2.3

10.0

385

R01AD01

ATC

beclometasone; nasal

1.6

10.0

244

1542

L01CA04

ATC

vinorelbine; systemic

14.6

10.0

F1246

NOMESCO Finland

40.1

9.9

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

40.1

9.9

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

40.1

9.9

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

7.2

9.9

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

7.2

9.9

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.2

9.9

163

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

9.9

1475

12871

L03.3

ICD-10 Finland

Cellulitis of trunk

6.7

9.9

UJC01

NOMESCO Finland

Scopy of lower throat

4.9

9.8

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.8

9.8

167

948

RS314

NOMESCO Finland

26.0

9.8

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

26.0

9.8

R03BC03

ATC

nedocromil; inhalant

2.0

9.8

120

607

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

8.7

9.7

M10.0

ICD-10 Finland

Idiopathic gout

2.2

9.7

422

WX890

NOMESCO Finland

Intesive care monitoring

4.5

9.7

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

1.9

9.7

134

710

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.3

9.7

359

S19

ICPC

Skin injury other

2.2

9.6

436

XX1AW

NOMESCO Finland

Written report from X-ray examination without contrast peformed elsewhere

13.4

9.6

TGD00

NOMESCO Finland

Needle biopsy of lung

13.4

9.6

M41.4

ICD-10 Finland

Neuromuscular scoliosis

55.0

9.6

F2682

NOMESCO Finland

55.0

9.6

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

5.3

9.6

F32.8

ICD-10 Finland

Other depressive episodes

5.5

9.6

N06AA10

ATC

nortriptyline; systemic

3.5

9.6

124

N06DA02

ATC

donepezil; oral

0.4

9.6

1153

SPAT1058

SPAT

PEF monitoring instruction

1.9

9.5

144

785

WX002

NOMESCO Finland

Sedation and analgesia

1.4

9.5

452

3313

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

4.5

9.5

N06AX12

ATC

bupropion; oral

2.5

9.5

283

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

4.1

9.5

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

4.1

9.5

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

9.1

9.5

M81.4

ICD-10 Finland

Drug-induced osteoporosis

9.1

9.5

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.1

9.5

163

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

5.7

9.5

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

9.5

644

5025

RF210

NOMESCO Finland

2.8

9.4

212

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

9.4

493

3680

R79

ICPC

Chronic bronchitis

30.0

9.4

G71.00

ICD-10 Finland

Muscular dystrophy benign [Becker]

30.0

9.4

J35.0

ICD-10 Finland

Chronic tonsillitis

17.5

9.4

P01BA02

ATC

hydroxychloroquine; oral

1.8

9.4

147

815

C34.36

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma

+∞

9.4

J70.2

ICD-10 Finland

Acute drug-induced interstitial lung disorders

+∞

9.4

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

+∞

9.4

GBB18

NOMESCO Finland

Closure of tracheostomy

+∞

9.4

J67.9

ICD-10 Finland

Hypersensitivity pneumonitis due to unspecified organic dust

+∞

9.4

GDB01

NOMESCO Finland

Thoracoscopic resection of bullae of lung

+∞

9.4

J21.0

ICD-10 Finland

Acute bronchiolitis due to respiratory syncytial virus

+∞

9.4

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

+∞

9.4

M05BX04

ATC

denosumab; parenteral

2.0

9.4

112

560

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

3.3

9.4

137

SPD00

NOMESCO Finland

Fitting and preparation of total teeth prosthesis

3.9

9.4

R51.80

ICD-10 Finland

Headache

1.7

9.3

209

1291

J33.8

ICD-10 Finland

Other polyp of sinus

21.7

9.3

N18

ICPC

Paralysis/weakness

2.8

9.3

215

L04AA01

ATC

[U] ciclosporin; systemic

4.2

9.3

XF640

NOMESCO Finland

2.3

9.3

386

L82

ICD-10 Finland

Seborrhoeic keratosis

0.6

9.3

166

2594

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

9.5

9.2

D07CC01

ATC

betamethasone and antibiotics; topical

1.6

9.2

268

1772

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

9.2

539

4100

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

4.0

9.2

UJD02

NOMESCO Finland

Gastroscopy

2.0

9.2

119

613

C07AB02

ATC

metoprolol; systemic

1.3

9.1

638

4994

ZZA00

NOMESCO Finland

Split skin graft

2.3

9.1

376

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

9.1

168

981

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.6

9.1

253

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.9

9.1

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.2

9.1

422

G72.8

ICD-10 Finland

Other specified myopathies

3.3

9.1

130

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.8

9.0

144

802

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.5

9.0

1498

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.4

9.0

300

EBA00

NOMESCO Finland

Extraction of tooth

1.3

9.0

666

5257

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.9

9.0

138

758

N05BE01

ATC

buspirone; oral

2.7

9.0

215

GBB96

NOMESCO Finland

Other tracheostomy procedure

36.7

9.0

RK290

NOMESCO Finland

10.0

9.0

5BA08

NOMESCO Finland

7.0

9.0

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

3.6

9.0

110

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.7

9.0

222

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.7

9.0

222

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

2.4

9.0

321

P03

ICPC

Feeling depressed

2.0

8.9

109

550

J01FA01

ATC

erythromycin; systemic

1.6

8.9

216

1360

R06AE09

ATC

levocetirizine; oral

1.6

8.9

205

1275

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.7

8.9

187

1134

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.6

8.9

234

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

8.9

231

1483

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

3.0

8.8

166

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

3.4

8.8

117

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

8.8

894

7388

30041

ICD-8 Finland

Neuroses, Depressiva

3.0

8.8

161

RF420

NOMESCO Finland

3.8

8.8

P72

ICPC

Schizophrenia

3.7

8.8

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

8.6

8.8

RS313

NOMESCO Finland

10.7

8.8

TFP20

NOMESCO Finland

Cardiodefibrillation

1.7

8.8

195

1202

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

8.7

254

1676

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

6.3

8.7

D01AC02

ATC

miconazole; topical

1.6

8.7

203

1266

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

9.5

8.7

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

5.1

8.7

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.1

8.7

452

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

4.1

8.7

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.9

8.7

171

ZXA00

NOMESCO Finland

Right side

1.3

8.7

655

5183

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

5.6

8.7

A01

ICPC

Pain general/multiple sites

1.8

8.7

159

925

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.5

8.7

108

L76

ICPC

Fracture: other

2.5

8.7

267

T78.4

ICD-10 Finland

Allergy, unspecified

2.5

8.7

257

R51

NOMESCO Finland

Aids services

14.0

8.7

XX4AW

NOMESCO Finland

14.0

8.7

D72.1

ICD-10 Finland

Eosinophilia

50.0

8.7

D38.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified

50.0

8.7

GA3AT

NOMESCO Finland

Pleural cytology with ultrasound guidance

50.0

8.7

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.4

8.6

114

A01AB10

ATC

natamycin; local oral

2.4

8.6

277

Z50.0

ICD-10 Finland

Cardiac rehabilitation

3.0

8.6

152

SPAT1097

SPAT

Recording of ECG

1.4

8.6

360

2574

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

8.6

652

5163

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.0

8.6

102

511

T05

ICPC

Feeding problem of adult

5.2

8.6

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.0

8.6

102

512

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.6

8.5

228

S70.0

ICD-10 Finland

Contusion of hip

2.1

8.5

416

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

8.5

781

6355

RS110

NOMESCO Finland

16.3

8.5

ZXE80

NOMESCO Finland

More than 18 and less than 21 hours

16.3

8.5

R06.4

ICD-10 Finland

Hyperventilation

4.2

8.5

P17

ICPC

Tobacco abuse

4.8

8.5

RS311

NOMESCO Finland

10.0

8.5

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

8.5

161

950

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

3.8

8.5

A10AB06

ATC

insulin glulisine; parenteral

3.7

8.5

1CX01

NOMESCO Finland

27.5

8.5

B90.2

ICD-10 Finland

Sequelae of tuberculosis of bones and joints

27.5

8.5

J38.7

ICD-10 Finland

Other diseases of larynx

27.5

8.5

N05AN01

ATC

lithium; oral

3.0

8.5

154

H25.8

ICD-10 Finland

Other senile cataract

1.5

8.5

343

2437

JDB00

NOMESCO Finland

Gastrostomy

20.0

8.4

G47.2

ICD-10 Finland

Disorders of the sleep-wake schedule

20.0

8.4

F2680

NOMESCO Finland

20.0

8.4

J01XE01

ATC

nitrofurantoin; oral

3.1

8.4

143

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.6

8.4

223

JN4CD

NOMESCO Finland

Very extensive body CT

2.0

8.4

481

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

6.0

8.4

F60.9

ICD-10 Finland

Personality disorder, unspecified

6.0

8.4

49101

ICD-8 Finland

Chronic bronchitis, Nonpurulenta (simplex)

7.3

8.4

J35.1

ICD-10 Finland

Hypertrophy of tonsils

90.0

8.4

G71.0

ICD-10 Finland

Muscular dystrophy

90.0

8.4

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

90.0

8.4

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

3.6

8.4

101

SPAT1139

SPAT

Nutrition survey

2.2

8.3

380

NAG53

NOMESCO Finland

Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea

12.7

8.3

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

3.4

8.3

112

WX900

NOMESCO Finland

Resuscitation

4.8

8.3

J15.0

ICD-10 Finland

Pneumonia due to Klebsiella pneumoniae

+∞

8.3

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

+∞

8.3

AK3

BLTX (both lung transplants)

+∞

8.3

B01AC27

ATC

selexipag; oral

+∞

8.3

C34.91

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma

+∞

8.3

B01AC11

ATC

iloprost; inhalant, parenteral

+∞

8.3

13597

ICD-8 Finland

Sarcoidosis, Suspecta

+∞

8.3

1350A

ICD-9 Finland

Sarcoidosis[SARCOIDOSIS]

+∞

8.3

C34.2

ICD-10 Finland

Malignant neoplasm: Middle lobe, bronchus or lung

+∞

8.3

B44.1

ICD-10 Finland

Other pulmonary aspergillosis

+∞

8.3

G71.03

ICD-10 Finland

Muscular dystrophy autosomal recessive, childhood type, resembling Duchenne or Becker

+∞

8.3

G71.06

ICD-10 Finland

Muscular dystrophy severe [Duchenne]

+∞

8.3

13599

ICD-8 Finland

Sarcoidosis, Unspecified

+∞

8.3

B90.0

ICD-10 Finland

Sequelae of central nervous system tuberculosis

+∞

8.3

C34.81

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma

+∞

8.3

4940A

ICD-9 Finland

Bronchiectasis[BRONCHIECTASIAE]

+∞

8.3

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

4.5

8.3

L16

ICPC

Ankle symptom/complaint

1.7

8.3

179

1093

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

8.3

169

1017

WW200

SPAT

0.5

8.3

1276

F20

ICD-10 Finland

Schizophrenia

8.5

8.3

5110B

ICD-9 Finland

Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]

8.5

8.3

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.0

8.3

151

N03AF02

ATC

oxcarbazepine; oral

2.4

8.3

271

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

5.8

8.3

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

9.4

8.2

N04BC05

ATC

pramipexole; oral

1.7

8.2

167

1004

AP1

Catheterization of the left side of the heart

2.7

8.2

204

B01AB04

ATC

dalteparin; parenteral

1.9

8.2

120

652

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

8.1

166

999

N05AF01

ATC

flupentixol; systemic

3.2

8.1

125

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

8.1

136

772

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.3

8.1

120

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.6

8.1

206

M41.9

ICD-10 Finland

Scoliosis, unspecified

3.7

8.1

R07.3

ICD-10 Finland

Other chest pain

1.6

8.1

185

1151

G12.1

ICD-10 Finland

Other inherited spinal muscular atrophy

33.3

8.1

Q32.21

ICD-10 Finland

Secondary congenital bronchomalacia

33.3

8.1

C03AA03

ATC

hydrochlorothiazide; oral

1.5

8.1

261

1768

N91.1

ICD-10 Finland

Secondary amenorrhoea

8.1

QBG10

NOMESCO Finland

Excision and repair of bedsore of trunk

17.1

8.1

6BA02

NOMESCO Finland

17.1

8.1

J01CA08

ATC

pivmecillinam; oral

1.3

8.0

650

5193

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

4.8

8.0

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

8.0

375

2737

G95.8

ICD-10 Finland

Other specified diseases of spinal cord

10.0

8.0

ZXD40

NOMESCO Finland

Procedure on patient requiring isolation

10.0

8.0

Z57.2

ICD-10 Finland

Occupational exposure to dust

22.0

8.0

TGW99

NOMESCO Finland

Other minor procedure in thoracic surgery

22.0

8.0

J02AC03

ATC

voriconazole; systemic

22.0

8.0

C02AC05

ATC

moxonidine; oral

1.9

8.0

116

627

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

5.0

8.0

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

8.0

924

7743

C01BD01

ATC

amiodarone; systemic

2.2

8.0

355

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

8.0

168

1024

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

5.2

8.0

M01AB51

ATC

indometacin, combinations; oral, rectal

2.3

7.9

295

XA402

NOMESCO Finland

ENMG

2.5

7.9

231

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.8

7.9

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.9

7.9

161

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

7.9

399

2955

G04BD04

ATC

oxybutynin; oral, transdermal

1.8

7.9

139

801

R62.0

ICD-10 Finland

Delayed milestone

13.0

7.9

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

13.0

7.9

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

3.4

7.8

102

S01BC05

ATC

ketorolac; ophthalmic

1.8

7.8

128

722

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

6.1

7.8

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.8

7.8

N07AA02

ATC

pyridostigmine; systemic

5.7

7.8

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

7.8

282

1957

SAA04

NOMESCO Finland

Special inverstigation of mouth

2.0

7.8

503

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

7.8

337

2426

F61

ICD-10 Finland

Mixed and other personality disorders

9.4

7.8

TK810

NOMESCO Finland

Hemofiltration

6.9

7.7

TAB00

NOMESCO Finland

Lumbar puncture

2.2

7.7

346

M70.2

ICD-10 Finland

Olecranon bursitis

2.1

7.7

380

S22.3

ICD-10 Finland

Fracture of rib

1.7

7.7

140

817

ZX197

NOMESCO Finland

44.9

7.7

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

44.9

7.7

SPAT1125

SPAT

Stoma care and guidance

2.5

7.7

237

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

5.0

7.7

DKW30

NOMESCO Finland

Cauterisation of artery of internal nose

5.0

7.7

S28

ICPC

Limited function/disability (S)

5.0

7.7

EMB10

NOMESCO Finland

Tonsillectomy

6.3

7.7

TQW80

NOMESCO Finland

Local dermatologic skincare

2.4

7.7

268

ZY000

NOMESCO Finland

Hospital inpatient

5.3

7.7

NXL00

NOMESCO Finland

Biopsy of muscle

7.4

7.6

ZXD35

NOMESCO Finland

Usual procedure

2.1

7.6

362

N06AG02

ATC

moclobemide; oral

2.0

7.6

436

S72.4

ICD-10 Finland

Fracture of lower end of femur

3.8

7.6

K78

ICPC

Atrial fibrillation/flutter

1.6

7.6

216

1420

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.4

7.6

751

B02.9

ICD-10 Finland

Zoster without complication

1.8

7.6

126

714

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

18.3

7.6

AP2

Catheterization of the right side of the heart

6.7

7.6

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

11.8

7.6

G12.9

ICD-10 Finland

Spinal muscular atrophy, unspecified

11.8

7.6

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

3.1

7.6

127

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

3.9

7.5

RK210

NOMESCO Finland

10.0

7.5

Z51.88

ICD-10 Finland

Other specified medical care

2.6

7.5

202

UJF92

NOMESCO Finland

Capsular endoscopy

3.1

7.5

128

V03AE01

ATC

polystyrene sulfonate; oral

3.2

7.5

117

R03

ICPC

Wheezing

4.6

7.5

SPAT1111

SPAT

Planning of analgesia

3.5

7.4

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

4.8

7.4

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

80.0

7.4

B44.0

ICD-10 Finland

Invasive pulmonary aspergillosis

80.0

7.4

383

Kela drug reimbursment

Selexipag

80.0

7.4

SPAT1279

SPAT

Preparation of immediate hospitalisation

3.2

7.4

118

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.1

7.4

375

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.1

7.4

354

WNF00

NOMESCO Finland

Infection source and contact determination

6.4

7.4

TAC99

NOMESCO Finland

Other blockade for chronic pain

5.3

7.3

ZXD00

NOMESCO Finland

Emergency procedure

2.1

7.3

381

U05

ICPC

Urination problems other

1.8

7.3

118

661

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.0

7.3

457

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

3.9

7.3

ZX114

NOMESCO Finland

Intramuscular

3.9

7.3

J99.0

ICD-10 Finland

Rheumatoid lung disease

+∞

7.3

GAC01

NOMESCO Finland

Endoscopic biopsy of pleura

+∞

7.3

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

+∞

7.3

01101

ICD-8 Finland

Pulmonary tuberculosis, Cavernosa

+∞

7.3

8041/3-C34.3

ICD-O-3

Small cell carcinoma, NOS, of lower lobe, lung

+∞

7.3

J01XB01

ATC

colistin; inhalant, parenteral

+∞

7.3

334

Kela drug reimbursment

Treprostinil

+∞

7.3

Q21.81

ICD-10 Finland

Eisenmenger's syndrome

+∞

7.3

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.2

7.3

330

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.0

7.3

419

Z22.3

ICD-10 Finland

Carrier of other specified bacterial diseases

10.8

7.3

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.3

7.3

274

J04AB02

ATC

rifampicin; systemic

3.4

7.3

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

6.8

7.3

DQA10

NOMESCO Finland

Biopsy of larynx

9.3

7.3

OAB95

SPAT

0.0

7.2

211

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.5

7.2

SPE90

NOMESCO Finland

Other fitting and preparation of partial tooth prosthesis

2.4

7.2

256

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.1

7.2

351

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

2.0

7.2

477

R50

ICPC

Respiratory, Medication/prescr/renewal

15.7

7.2

Z03

ICPC

Housing/neighbourhood problem

5.1

7.2

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.2

7.2

308

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.4

7.2

247

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

4.6

7.2

N06AA04

ATC

clomipramine; systemic

3.1

7.2

121

ZXA05

NOMESCO Finland

Left side

1.3

7.2

604

4845

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.0

7.1

429

A10BJ01

ATC

exenatide; parenteral

4.1

7.1

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

7.1

217

1452

RF410

NOMESCO Finland

3.5

7.1

EMB30

NOMESCO Finland

Adenotomy

20.0

7.1

J34.1

ICD-10 Finland

Cyst and mucocele of nose and nasal sinus

20.0

7.1

K56.0

ICD-10 Finland

Paralytic ileus

3.7

7.1

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

4.8

7.1

M05BA01

ATC

etidronic acid; systemic

4.8

7.1

I24.9

ICD-10 Finland

Acute ischaemic heart disease, unspecified

4.8

7.1

N29

ICPC

Neurological sympt/complt other

2.6

7.1

186

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

3.2

7.1

111

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.9

7.1

143

A50

ICPC

General and Unspecified, Medication/prescr/renewal

2.1

7.1

373

XX3DW

NOMESCO Finland

Time consuming IT work

1.5

7.1

213

1422

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

0.7

7.1

232

3224

RS224

NOMESCO Finland

12.0

7.1

L95.8

ICD-10 Finland

Other vasculitis limited to skin

12.0

7.1

5119X

ICD-9 Finland

Pleurisy, Unspecified pleural effusion

6.0

7.0

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

4.5

7.0

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.4

7.0

224

-69

ICPC

Other reason for encounter NEC

1.9

7.0

509

RS211

NOMESCO Finland

10.0

7.0

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

4.3

7.0

N18.0

ICD-10 Finland

End-stage renal disease

3.3

7.0

C08CA02

ATC

felodipine; oral

1.5

7.0

272

1919

H02

ICPC

Hearing complaint

0.7

7.0

167

2456

S06

ICPC

Rash localized

1.8

7.0

113

635

R1260

NOMESCO Finland

Evaluation of communicative skills

2.6

7.0

193

G04BD07

ATC

tolterodine; oral

1.7

6.9

126

737

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

4.9

6.9

ECB00

NOMESCO Finland

Suture of gingiva

2.1

6.9

379

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

4.0

6.9

SPD01

NOMESCO Finland

Mucosa-supported complete denture

4.0

6.9

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

3.8

6.9

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

4.4

6.9

M80.5

ICD-10 Finland

Idiopathic osteoporosis with pathological fracture

6.3

6.9

R5110

SPAT

2.2

6.9

302

A10BK01

ATC

dapagliflozin; oral

1.9

6.9

477

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

5.4

6.9

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

7.5

6.9

Z43.1

ICD-10 Finland

Attention to gastrostomy

13.7

6.9

A08.3

ICD-10 Finland

Other viral enteritis

13.7

6.9

-34

ICPC

Blood test

2.2

6.9

304

W06

ICD-10 Finland

Fall involving bed

3.9

6.8

S91.0

ICD-10 Finland

Open wound of ankle

3.9

6.8

SPAT1127

SPAT

Enema

3.6

6.8

XKC03

NOMESCO Finland

Water cystometry

2.1

6.8

327

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

4.8

6.8

R03CC03

ATC

terbutaline; systemic

4.4

6.8

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

0.7

6.8

200

2831

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

3.0

6.8

126

K20

ICD-10 Finland

Oesophagitis

2.9

6.8

135

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

6.8

664

5429

NGA20

NOMESCO Finland

Exploration of soft tissue knee or lower leg, open

9.3

6.8

M40.2

ICD-10 Finland

Other and unspecified kyphosis

9.3

6.8

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.7

6.8

166

A10BK03

ATC

empagliflozin; oral

1.7

6.8

146

897

N05AL01

ATC

sulpiride; systemic

2.9

6.7

136

K23.8

ICD-10 Finland

Disorders of oesophagus in other diseases classified elsewhere

40.0

6.7

JDB01

NOMESCO Finland

Laparoscopic gastrostomy

40.0

6.7

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.1

6.7

356

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.8

6.7

R4120

NOMESCO Finland

Occupational therapy

1.7

6.7

122

713

M48.0

ICD-10 Finland

Spinal stenosis

1.4

6.7

281

2008

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

2.3

6.7

248

X58

ICD-10 Finland

Exposure to other specified factors

1.5

6.7

228

1565

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

4.3

6.7

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

6.7

246

1714

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

6.7

236

1630

K55.9

ICD-10 Finland

Vascular disorder of intestine, unspecified

7.1

6.7

ZXF00

NOMESCO Finland

Interruption caused by intraoperative deterioration of general condition

7.1

6.7

RK120

NOMESCO Finland

7.1

6.7

-56

ICPC

Dressing/pressure/compress/tamponade

2.6

6.7

185

ZX100

NOMESCO Finland

Oral

2.8

6.7

138

I28.9

ICD-10 Finland

Disease of pulmonary vessels, unspecified

22.5

6.7

Z73.6

ICD-10 Finland

Limitation of activities due to disability

3.6

6.6

Z72.1

ICD-10 Finland

Alcohol use

3.9

6.6

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

0.6

6.6

1307

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

4.9

6.6

R05DB05

ATC

pentoxyverine; oral, rectal

2.0

6.6

377

G35

ICD-10 Finland

Multiple sclerosis

4.4

6.6

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

6.4

6.6

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

5.1

6.6

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

7.8

6.6

A02BX02

ATC

sucralfate; oral

1.8

6.6

108

613

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.0

6.5

118

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

3.0

6.5

118

F20.8

ICD-10 Finland

Other schizophrenia

8.7

6.5

F60.8

ICD-10 Finland

Other specific personality disorders

8.7

6.5

EBA10

NOMESCO Finland

Surgical removal of tooth

1.6

6.5

160

1018

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.3

6.5

234

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.8

6.5

539

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.3

6.5

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

6.5

102

571

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

6.5

389

2964

M03BX02

ATC

tizanidine; oral

1.2

6.5

1130

9871

49099

ICD-8 Finland

Bronchitis, unspecified

3.5

6.5

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

3.9

6.4

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.6

6.4

F43.29

ICD-10 Finland

Adaptation disorder UNS

3.7

6.4

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

0.8

6.4

779

9084

J41.8

ICD-10 Finland

Mixed simple and mucopurulent chronic bronchitis

69.8

6.4

G71.25

ICD-10 Finland

Congenital muscular dystrophy NOS

69.8

6.4

J84

ICD-10 Finland

Other interstitial pulmonary diseases

69.8

6.4

J21.90

ICD-10 Finland

Acute obstructive bronchitis in children

69.8

6.4

ABD40

NOMESCO Finland

Implantation of spinal injection device

69.8

6.4

OAA67

SPAT

0.3

6.4

413

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

2.7

6.4

143

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.3

6.4

L99

ICPC

Musculoskeletal disease other

2.6

6.4

160

I87.0

ICD-10 Finland

Postthrombotic syndrome

7.4

6.4

AP3

Catheterization of the right and left side of the heart

7.4

6.4

J39.9

ICD-10 Finland

Disease of upper respiratory tract, unspecified

14.3

6.4

M34.0

ICD-10 Finland

Progressive systemic sclerosis

14.3

6.4

N06AB05

ATC

paroxetine; oral

1.9

6.4

477

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.4

6.4

D02AE01

ATC

carbamide; topical

1.7

6.4

122

725

N05CF02

ATC

zolpidem; oral

1.4

6.4

291

2115

D01AC03

ATC

econazole; topical

1.7

6.4

137

840

R49.08

ICD-10 Finland

Other specified dysphonia

3.2

6.3

H65.3

ICD-10 Finland

Chronic mucoid otitis media

3.7

6.3

S72.0

ICD-10 Finland

Fracture of neck of femur

1.8

6.3

108

621

NHQ40

NOMESCO Finland

Amputation of toe

2.5

6.3

196

A96

ICPC

Death

4.4

6.3

XF620

NOMESCO Finland

Examination of circulation with color method

6.5

6.3

N86

ICPC

Multiple sclerosis

6.5

6.3

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.2

6.3

289

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

11.0

6.3

N07BC02

ATC

methadone; systemic

11.0

6.3

R24

ICPC

Haemoptysis

5.9

6.3

WX110

NOMESCO Finland

Local anesthesy

1.2

6.3

1386

12389

315

Kela drug reimbursment

Clopidogrel

2.7

6.3

139

R01AD05

ATC

budesonide; nasal

1.8

6.3

107

615

TFC99

NOMESCO Finland

Catheterisation of heart with other procedure

18.0

6.2

G71.8

ICD-10 Finland

Other primary disorders of muscles

18.0

6.2

E66.1

ICD-10 Finland

Drug-induced obesity

18.0

6.2

J85.2

ICD-10 Finland

Abscess of lung without pneumonia

+∞

6.2

C02KX02

ATC

ambrisentan; oral

+∞

6.2

J38.5

ICD-10 Finland

Laryngeal spasm

+∞

6.2

B01AC21

ATC

treprostinil; parenteral

+∞

6.2

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

+∞

6.2

J14

ICD-10 Finland

Pneumonia due to Haemophilus influenzae

+∞

6.2

01102

ICD-8 Finland

Pulmonary tuberculosis, Non cavernosa

+∞

6.2

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

+∞

6.2

A220_

NOMESCO Finland

+∞

6.2

J15.2

ICD-10 Finland

Pneumonia due to staphylococcus

+∞

6.2

J69.8

ICD-10 Finland

Pneumonitis due to other solids and liquids

+∞

6.2

EMA00

NOMESCO Finland

Incision of tonsil

+∞

6.2

F17.3

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, withdrawal state

+∞

6.2

C34.35

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other non-microcellular carcinoma

+∞

6.2

A15.2

ICD-10 Finland

Tuberculosis of lung, confirmed histologically

+∞

6.2

G04BD09

ATC

trospium; oral

2.1

6.2

313

K28

ICPC

Limited function/disability (K)

2.2

6.2

270

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

3.1

6.2

100

WPA13

NOMESCO Finland

Palliative consultation

26.6

6.2

A211_

NOMESCO Finland

26.6

6.2

J98.9

ICD-10 Finland

Respiratory disorder, unspecified

26.6

6.2

A69.2

ICD-10 Finland

Lyme disease

0.4

6.2

610

A07EC01

ATC

sulfasalazine; oral, rectal

1.6

6.2

142

885

N30.2

ICD-10 Finland

Other chronic cystitis

4.3

6.2

C09CA01

ATC

losartan; oral

1.3

6.2

568

4601

F32.1

ICD-10 Finland

Moderate depressive episode

2.2

6.2

251

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.0

6.2

409

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.5

6.2

183

L30.3

ICD-10 Finland

Infective dermatitis

2.1

6.2

320

PD4BD

NOMESCO Finland

Extensive CT of lower extremity arteries

5.0

6.2

ZXF05

NOMESCO Finland

Interruption of procedure for other patient related reason

5.0

6.2

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

3.6

6.1

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

2.7

6.1

151

Z29

ICPC

Social problem NOS

2.7

6.1

151

30180

ICD-8 Finland

Personality disorders, Immatura

6.3

6.1

3004A

ICD-9 Finland

Neurotic disorders, Neurotic depression

5.3

6.1

L30.4

ICD-10 Finland

Erythema intertrigo

3.1

6.1

D05AX52

ATC

calcipotriol, combinations; topical

1.7

6.1

109

634

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

6.1

550

N05BB01

ATC

hydroxyzine; systemic

1.7

6.1

121

725

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

3.4

6.1

J01MA01

ATC

ofloxacin; systemic

1.5

6.1

213

1469

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

6.1

480

3811

SPAT1153

SPAT

Removal of sutures

0.8

6.1

526

6372

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

12.5

6.1

R03DB04

ATC

theophylline and adrenergics; systemic

12.5

6.1

J01DC04

ATC

cefaclor; oral

4.0

6.1

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.6

6.1

131

807

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

3.6

6.0

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

3.8

6.0

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.8

6.0

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.0

6.0

352

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

1.8

6.0

540

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

1.9

6.0

421

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

6.0

485

3857

R55

ICD-10 Finland

Syncope and collapse

1.4

6.0

254

1820

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

10.0

6.0

DHA10

NOMESCO Finland

Biopsy of cavity of nose

6.7

6.0

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

4.4

6.0

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

4.4

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

511

792

7.40

321.93

12.7

3.7

mmol/l

27.1

24.3

48.64

501

699

(3023419) Bacteria identified in Sputum by Culture

325

65.10

307.65

3.1

1.2

—

(3027315) Oxygen [Partial pressure] in Blood

408

385

11.88

307.65

13.4

2.5

kpa

7.8

8.8

14.83

401

376

(3021901) Oxygen saturation in Capillary blood

386

319

13.50

307.65

6.2

2.3

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1465

2410

9.91

307.65

10.8

5.9

kpa

5.9

5.0

100.99

1399

2317

(3016502) Oxygen saturation in Arterial blood

1200

2240

7.72

307.65

10.9

6.1

90.7

96.3

90.72

1150

2161

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

270

155

18.80

307.65

2.4

1.3

—

(1616796) Gas panel - Central venous blood

444

363

13.89

307.65

9.6

2.6

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1464

2408

9.90

307.65

10.8

5.9

kpa

8.6

13.3

214.35

1398

2315

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

954

1220

10.46

307.65

10.5

3.4

kpa

6.0

5.0

91.55

934

1097

(3019060) Gas panel - Arterial blood

1415

1259

18.51

307.65

5.5

4.1

—

(3022313) Gas panel - Capillary blood

680

877

9.42

307.65

10.9

3.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

944

1157

10.89

307.65

10.0

3.4

mmol/l

4.4

1.1

73.13

866

792

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

337

231

16.05

307.65

2.7

1.3

—

(3009343) pH of Capillary blood

953

1200

10.63

307.65

10.4

3.4

7.4

0.82

172

146

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

859

2072

5.20

307.65

3.0

1.5

—

(3003396) Base excess in Arterial blood by calculation

1448

2424

9.65

307.65

10.9

5.9

mmol/l

3.7

0.5

109.68

1292

1846

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

864

2100

5.17

307.65

3.0

1.5

—

(3013290) Carbon dioxide [Partial pressure] in Blood

403

386

11.69

307.65

13.5

2.5

kpa

5.9

4.8

47.35

396

377

(3010421) pH of Blood

418

463

10.13

307.65

13.4

2.6

7.4

1.47

395

378

(3028626) Oxygen [Partial pressure] in Capillary blood

473

446

12.13

307.65

7.9

3.7

kpa

7.4

8.5

22.87

463

413

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

854

1071

10.29

307.65

11.1

8.1

mmol/l

26.5

23.7

62.43

791

1011

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

272

141

20.84

307.65

2.4

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

351

234

16.58

307.65

2.6

1.2

—

(3012501) Base excess in Blood by calculation

402

386

11.65

307.65

13.5

2.5

mmol/l

4.6

2.3

22.35

365

225

(3015235) Bicarbonate [Moles/volume] in Capillary blood

500

461

12.52

307.65

7.6

2.6

mmol/l

28.1

24.0

36.00

475

401

(3023368) Bacteria identified in Blood by Culture

1652

5850

4.54

307.65

6.9

3.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1236

3105

5.67

307.65

3.1

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

408

300

15.29

307.65

3.7

2.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

629

1257

5.90

307.24

16.9

6.3

mmol/l

28.5

24.3

61.80

621

1249

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

262

171

16.48

303.90

2.6

1.2

—

(3042631) Mycobacterium sp identified in Specimen

216

23.18

294.74

3.3

2.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

234

130

19.22

293.76

2.6

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

221

109

21.57

292.52

2.8

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

180

35.07

283.93

4.1

2.8

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

808

2133

4.65

283.61

13.9

6.3

g/l

130.9

119.5

34.24

788

2057

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

217

112

20.59

281.54

2.4

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

161

52.66

280.71

3.1

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

207

102

21.50

273.94

1.9

1.3

—

(3017569) Oxygen content in Arterial blood

198

23.00

269.67

2.8

1.6

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

617

1373

5.26

265.42

12.1

5.6

mmol/l

28.0

23.9

70.08

593

1271

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

218

131

17.68

263.31

2.0

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

170

29.71

254.86

1.2

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

239

194

13.15

244.49

2.0

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

239

194

13.15

244.49

2.0

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

312

381

8.90

239.55

5.4

2.0

16.5

16.4

0.08

215

198

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1671

7926

3.17

235.03

5.8

2.7

ng/l

2298.7

1602.5

5.07

1532

6835

(3006184) Hemoglobin [Mass/volume] in Capillary blood

326

438

8.11

231.17

4.1

2.0

g/l

136.2

129.1

3.41

241

342

(3019977) pH of Arterial blood

184

108

17.92

224.50

3.0

1.7

7.4

0.05

140

(42870588) Differential panel, method unspecified - Blood

1487

6943

3.02

209.24

9.1

4.8

—

(3022096) Basophils/100 leukocytes in Blood

1778

9341

2.89

198.16

9.2

5.0

0.5

0.7

32.47

1694

8474

(44790049)

166

105

16.54

194.91

3.2

1.3

—

(44790047)

166

105

16.54

194.91

3.2

1.3

—

(44790048)

166

105

16.54

194.91

3.2

1.3

—

(44806118)

166

105

16.54

194.91

3.2

1.3

—

(4010399)

433

920

5.24

193.98

1.9

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

388

754

5.67

191.99

2.5

1.7

ug/l

1.8

3.1

0.86

339

634

(3006504) Eosinophils/100 leukocytes in Blood

1797

9659

2.82

188.99

9.3

4.9

2.2

2.9

28.99

1711

8757

(3019069) Monocytes/100 leukocytes in Blood

1798

9705

2.80

186.94

9.7

5.2

8.6

9.0

4.60

1713

8832

(3012095) Magnesium [Moles/volume] in Serum or Plasma

901

3354

3.29

184.66

6.9

2.8

mmol/l

0.8

0.37

824

3075

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

116

34.21

182.12

3.9

2.6

—

(3002030) Lymphocytes/100 leukocytes in Blood

1805

9918

2.74

178.69

9.5

5.1

20.3

27.5

140.05

1711

8950

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

143

17.48

173.08

2.2

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

816

2967

3.30

172.69

8.0

4.7

mmol/l

1.1

1.0

5.66

743

2738

(3020779) Urea [Moles/volume] in Serum or Plasma

660

2107

3.64

171.56

11.4

5.7

mmol/l

11.8

10.8

2.03

627

1979

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1008

4164

3.01

170.98

2.7

1.6

mg/l

1.4

1.5

0.41

830

3191

(3020891) Body temperature

408

918

4.90

170.17

7.6

3.9

—

(3018010) Neutrophils/100 leukocytes in Blood

1757

9777

2.64

165.63

9.2

4.9

65.0

57.4

118.28

1676

8881

(3002032) Base excess in Venous blood by calculation

681

2304

3.44

161.03

5.3

3.4

mmol/l

5.0

1.5

52.51

587

1808

(3012544) pH of Venous blood

695

2388

3.39

160.27

5.2

3.4

7.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

110

26.98

160.08

1.3

1.0

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

678

2303

3.42

159.17

5.3

3.4

kpa

7.1

5.7

67.33

641

2240

(3013115) Eosinophils [#/volume] in Blood

1847

10666

2.60

159.13

9.5

4.8

e9/l

0.2

2.10

1672

8988

(3001604) Monocytes [#/volume] in Blood

1798

10280

2.58

157.76

8.7

4.7

e9/l

0.7

0.6

42.46

1626

8542

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

457

1198

4.24

156.58

1.8

1.3

—

(3006315) Basophils [#/volume] in Blood

1805

10367

2.57

156.44

8.7

4.7

e9/l

0.0

0.30

1635

8632

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

455

1205

4.20

153.66

19.3

7.8

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

114

20.99

150.43

2.1

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

421

1069

4.34

150.24

4.5

3.6

mmol/l

26.7

23.7

32.53

389

946

(3019198) Lymphocytes [#/volume] in Blood

1809

10589

2.51

147.75

8.9

4.8

e9/l

1.7

1.9

4.88

1645

8945

(3014111) Lactate [Moles/volume] in Serum or Plasma

604

1993

3.46

147.71

14.9

5.7

mmol/l

1.4

0.45

560

1935

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

106

23.70

147.08

2.2

1.2

—

(3000991) Gas panel - Venous blood

595

1954

3.47

146.52

15.5

6.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

105

23.47

145.14

2.2

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

188

236

8.36

140.21

1.6

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

626

2201

3.25

137.47

5.7

2.5

ng/l

283.2

243.8

0.99

593

2010

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

477

1439

3.68

133.10

1.9

1.4

—

(3042936) Bacteria identified in Isolate by Culture

704

2841

2.86

119.92

3.1

1.9

—

(3005322) IgE [Units/volume] in Serum or Plasma

264

557

5.04

117.82

1.3

1.1

u/ml

189.0

236.4

0.52

240

494

(3005719) IgG [Mass/volume] in Serum or Plasma

409

1214

3.69

116.28

3.4

2.1

g/l

9.7

10.9

5.81

376

1088

(3000492) Spirometry study

388

1124

3.76

114.27

2.5

1.3

—

(3047181) Lactate [Moles/volume] in Blood

272

629

4.60

108.51

11.7

4.8

mmol/l

1.3

0.07

244

548

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

298

750

4.25

106.57

7.5

2.9

u/ml

0.3

0.4

1.40

188

404

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

174

276

6.58

105.05

18.9

4.2

iu/ml

759.6

455.5

0.31

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

315

844

4.00

103.40

2.9

1.6

—

(3003434) Protein [Mass/volume] in Pleural fluid

123

134

9.47

102.35

1.5

1.3

g/l

31.5

26.7

2.99

115

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1738

11096

2.15

102.17

13.7

4.9

mmol/l

1.2

22.82

1589

9813

(3009445) Proteinase 3 Ab [Units/volume] in Serum

274

688

4.24

98.13

1.4

1.2

u/ml

17.8

7.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

336

989

3.65

96.14

2.0

1.8

g/l

1.0

1.5

4.61

308

867

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

104

10.89

95.98

2.5

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

584

2382

2.75

95.76

2.4

1.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1824

12083

2.09

94.68

8.4

5.3

umol/l

11.7

13.2

6.58

1737

11377

(3013650) Neutrophils [#/volume] in Blood by Automated count

1869

12512

2.09

94.07

12.0

7.1

e9/l

5.4

4.1

85.94

1694

10612

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

293

797

3.92

93.96

2.7

1.5

—

(4015189)

35.23

93.42

2.2

1.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1544

9660

2.09

92.96

7.3

3.3

ng/l

95.9

64.2

0.28

1334

7325

(40757373) Influenza virus identified in Isolate

49.76

92.93

2.7

1.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

107

111

9.90

92.27

2.4

1.2

—

(3032080) INR in Blood by Coagulation assay

1654

10639

2.07

92.12

17.0

9.5

inr

1.4

1.3

1.06

542

2909

(3012441) Differential panel - Pleural fluid

103

102

10.36

91.82

1.5

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

406

1391

3.17

91.09

2.4

1.5

—

(3024354) Oxygen [Partial pressure] in Venous blood

502

1941

2.86

90.84

5.5

2.9

kpa

4.7

4.4

2.28

470

1885

(3042733) HLA Ab [Presence] in Serum

19.50

88.42

5.0

3.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

716

3358

2.43

87.15

3.4

2.3

17.4

22.9

23.16

601

2845

(40768806) Pleura Pathology biopsy report

10.46

85.35

1.7

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

222

528

4.42

85.15

1.9

1.4

titre

131.3

374.2

1.06

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

521

2137

2.69

83.75

2.5

2.1

g/l

0.2

2.35

478

1984

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

212

500

4.45

82.16

1.8

1.6

—

(3010375) cycloSPORINE [Mass/volume] in Blood

14.58

80.89

45.6

20.1

ug/l

166.6

119.1

3.12

(3024561) Albumin [Mass/volume] in Serum or Plasma

1631

10783

1.98

80.51

6.4

4.1

g/l

32.1

35.3

89.05

1505

9883

(3022948) Iron [Moles/volume] in Serum or Plasma

776

3890

2.28

80.33

3.4

2.2

umol/l

10.0

12.9

25.78

708

3544

(46235355) HIV 1 and 2 tests - Meaningful Use set

453

1767

2.80

80.09

1.6

1.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

731

3595

2.31

79.04

3.4

2.2

g/l

2.3

2.43

670

3279

(3014007) Fractional oxyhemoglobin in Arterial blood

403

1487

2.93

78.95

19.8

7.1

88.9

94.6

26.63

396

1482

(3000494) Fungus identified in Specimen by Culture

518

2182

2.62

78.62

2.8

1.3

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

657

3100

2.38

78.07

15.3

5.6

mmol/l

102.3

104.8

21.73

631

3036

(3037522) Nuclear Ab [Titer] in Serum

509

2133

2.62

78.04

1.4

1.3

titre

488.2

553.8

0.41

136

460

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1805

12463

1.95

77.30

13.3

5.4

mmol/l

1.2

27.43

1468

10379

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

313

1011

3.30

77.02

7.4

4.0

2.2

1.5

10.94

294

959

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

131

214

6.31

76.70

7.9

2.7

u/ml

1451.3

1832.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

102

127

8.23

76.32

1.5

1.3

e6/l

3584.3

985.7

1.37

(3026782) Osmolality of Urine

898

4868

2.14

75.97

4.2

2.6

mosm/kgh2o

517.0

566.6

11.78

798

4068

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1926

24369

0.51

75.57

4.8

5.3

mmol/l

2.3

2.6

35.63

1676

21929

(3036481) Cortisol [Moles/volume] in Serum or Plasma

399

1507

2.86

74.72

2.0

2.1

nmol/l

331.5

379.6

3.70

364

1361

(3035880) pH of Pleural fluid

17.01

74.54

1.4

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

260

770

3.57

73.26

3.8

2.1

ug/l

415.2

909.1

1.08

247

732

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

392

1482

2.85

73.22

20.3

7.1

0.6

0.7

5.82

386

1473

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

226

612

3.88

72.61

1.4

1.2

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

391

1493

2.82

71.62

20.1

6.9

1.7

1.3

8.38

385

1485

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1846

23498

0.53

70.23

4.5

4.6

mmol/l

1.3

1.4

21.52

1589

21087

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1881

23759

0.53

68.75

4.5

4.6

mmol/l

4.2

4.5

29.38

1638

21477

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1095

6578

1.98

68.72

4.6

2.9

u/l

31.4

35.8

1.54

1029

6200

(3039000) Anion gap in Blood

184

452

4.24

67.50

10.3

5.6

mmol/l

10.3

11.3

3.19

169

407

(3018572) Chloride [Moles/volume] in Blood

184

452

4.24

67.50

10.3

5.6

mmol/l

102.4

105.6

14.31

169

407

(3037692) Legionella sp identified in Specimen by Organism specific culture

94.39

67.09

2.7

1.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

110

8.26

66.97

1.3

e6/l

153225.6

35044.3

0.96

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

9.59

66.83

1.6

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

9.59

66.83

1.6

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

9.59

66.83

1.6

1.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1978

14495

1.87

66.27

12.8

3.9

mmol/l

7.2

6.9

6.01

1896

13499

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

846

4745

2.04

63.74

6.6

3.4

ng/l

421.6

776.6

0.88

759

4013

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

194

521

3.88

62.97

9.1

2.4

90.8

86.7

1.69

187

489

(3023183) Ammonium ion [Moles/volume] in Plasma

172

426

4.19

62.38

2.3

3.1

umol/l

36.2

36.3

0.02

151

354

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

189

505

3.90

61.78

6.6

2.6

g/l

3.7

3.4

1.82

181

475

(3007930) Methemoglobin/Hemoglobin.total in Blood

283

994

3.01

60.06

8.1

4.0

0.8

0.9

0.33

265

942

(4306422)

113

204

5.68

59.68

1.4

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

542

2635

2.25

58.69

7.1

3.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

12.56

58.00

1.7

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

12.56

58.00

1.7

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

12.56

58.00

1.7

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

12.56

58.00

1.7

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

14.23

56.93

3.0

1.2

—

(4062490)

8.54

56.55

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

110

204

5.53

56.44

1.3

1.1

112.7

115.0

0.24

104

174

(3024471) HLA-A [Type]

13.42

56.12

1.0

—

(3026008) Bacteria identified in Urine by Culture

1178

7649

1.82

55.62

4.3

3.1

—

(3024932) HLA-DR beta [Type]

13.09

55.31

1.0

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

8.42

55.16

1.3

g/l

0.4

0.5

1.05

(3027135) IgG subclass 1 [Mass/volume] in Serum

8.42

55.16

1.3

g/l

6.0

6.9

0.79

(3028192) IgG subclass 2 [Mass/volume] in Serum

8.42

55.16

1.3

g/l

2.0

3.0

4.20

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

535

2649

2.21

55.14

3.2

3.6

u/l

264.8

246.3

1.59

495

2476

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1822

22688

0.57

53.73

4.2

4.1

mmol/l

1.4

1.2

19.94

1555

20151

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

174

485

3.72

53.47

4.4

2.5

207.4

198.7

0.56

169

456

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

110

217

5.19

52.71

1.4

1.1

u/ml

4.7

4.1

0.15

(3020630) Protein [Mass/volume] in Serum or Plasma

425

1952

2.34

52.28

1.8

2.0

g/l

64.5

66.6

6.43

381

1718

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1963

23902

0.57

52.20

5.2

4.9

mmol/l

6.3

6.1

8.48

1698

21187

(3040151) Glucose [Moles/volume] in Capillary blood

124

276

4.62

51.53

9.2

5.4

mmol/l

7.6

7.3

0.42

115

225

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1093

7069

1.80

51.42

3.1

2.3

u/l

50.8

61.8

13.41

1006

6455

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

15.87

51.10

8.5

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

193

594

3.38

50.98

1.5

1.2

u/l

36.2

38.5

0.80

161

483

(3000850) Epithelial cells [#/volume] in Urine

872

5273

1.87

50.97

4.1

2.5

e6/l

5.2

4.2

2.26

786

4564

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

108

219

5.05

50.15

1.3

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

114

244

4.79

49.68

1.4

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

108

222

4.98

49.37

9.9

6.1

mg/l

11.8

12.0

0.10

208

(3018405) Lactate [Moles/volume] in Arterial blood

227

804

2.95

47.27

7.9

3.2

mmol/l

1.3

1.5

2.47

217

796

(3018418) pH of Serum or Plasma

1082

7122

1.76

47.07

6.1

3.3

7.4

0.13

346

1283

(3002582) Erythrocytes [#/volume] in Urine

1145

7679

1.74

46.49

5.3

3.1

e6/l

96.6

124.8

0.40

967

5865

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1016

6589

1.77

46.41

2.9

2.2

mg/l

4.5

3.0

24.25

869

5521

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

145

393

3.80

46.38

1.6

1.3

g/l

0.3

0.2

1.23

132

367

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

75.39

46.01

3.6

1.1

—

(3011412) CD3 cells [#/volume] in Blood

111

6.69

45.77

1.7

2.5

e9/l

1.1

0.11

(3036489) Thrombin time

205

703

3.03

45.18

5.1

2.0

21.8

21.6

0.17

188

631

(3017181) Myelocytes/100 leukocytes in Blood

377

1747

2.30

45.13

5.3

3.7

1.2

0.9

0.97

150

441

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

13.68

44.98

1.7

1.4

58.2

69.9

0.78

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

121

294

4.22

44.97

1.7

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

111

6.59

44.56

4.0

1.6

—

(3034426) Prothrombin time (PT)

12.34

44.34

1.3

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

105

232

4.63

44.03

1.4

1.2

u/ml

3.9

4.2

0.05

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

146

413

3.64

43.87

1.6

1.3

g/l

1.2

0.52

134

386

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

466

2377

2.11

43.86

2.7

umol/l

7.7

9.8

2.33

395

2071

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

12.85

43.37

1.6

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

12.85

43.37

1.6

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

12.85

43.37

1.7

1.2

—

(36304419) Bacteria [Presence] in Urine

1009

6644

1.73

43.08

5.2

3.0

—

(4268621)

132

5.93

42.92

2.4

2.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

109

256

4.36

42.34

1.7

1.4

u/ml

114.0

107.7

0.30

(40760892) CBC W Ordered Manual Differential panel - Blood

710

4242

1.85

42.04

6.9

3.8

—

(3045788) Cell count panel - Pleural fluid

109

6.43

41.72

1.3

—

(3030467) Casts [#/volume] in Urine by Automated count

1041

6991

1.70

40.96

5.2

3.0

e6/l

0.7

0.4

2.68

878

5261

(3002179) Metamyelocytes/100 leukocytes in Blood

345

1605

2.27

40.77

5.3

3.5

0.9

0.5

1.08

119

318

(3001893) Eosinophils/100 leukocytes in Pleural fluid

15.12

40.73

1.7

1.5

2.0

0.00

(3024928) Oxygen saturation in Venous blood

149

453

3.39

40.08

3.2

3.3

—

(3009871) Measles virus Ab [Titer] in Serum

12.69

39.97

1.2

1.8

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

15.33

39.89

1.6

1.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

183

4.84

38.73

1.4

g/l

0.6

0.9

1.22

142

(3027456) Digoxin [Moles/volume] in Serum or Plasma

161

532

3.12

37.79

3.6

3.0

nmol/l

0.9

0.8

0.97

130

398

(3021440) Promyelocytes/100 leukocytes in Blood

347

1668

2.20

37.76

5.3

3.7

0.1

0.10

145

408

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

122

339

3.69

37.64

1.6

1.2

mg/l

10.9

11.8

0.47

111

301

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

7.18

37.61

1.8

2.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

121

5.79

37.58

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

409

2105

2.07

37.27

6.7

3.2

mmol/l

1.2

11.51

380

1770

(3027945) Reticulocytes/100 erythrocytes in Blood

546

3116

1.89

36.90

3.0

2.1

2.0

1.7

11.07

466

2729

(3025159) Blasts/100 leukocytes in Blood

331

1580

2.21

36.62

5.3

3.7

0.1

0.2

0.63

131

351

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1088

7570

1.64

36.46

3.5

2.0

u/l

241.8

227.2

0.08

1014

7062

(1175426) CD3 cells/100 lymphocytes in Blood

6.71

36.01

1.7

2.5

69.9

68.5

0.18

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

18.23

35.95

1.6

1.1

ug/l

212.8

1993.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

318

1506

2.22

35.85

1.7

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

286

1303

2.30

35.37

6.1

3.0

mmol/l

28.8

24.7

27.87

267

1261

(40761536) Microorganisms panel - Urine sediment

384

1968

2.07

35.31

6.4

3.6

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

621

3739

1.80

35.20

4.9

1.9

31.1

30.1

2.62

602

3625

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

136

5.30

35.19

1.2

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

6.67

35.18

1.7

2.4

13.5

14.9

0.23

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

647

9898

0.57

35.16

3.4

4.8

21.3

22.6

1.08

283

5405

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

109

5.86

34.80

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

6.96

34.67

1.8

2.2

e6/l

560.2

451.6

0.65

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

113

5.74

34.62

2.4

2.5

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

129

5.35

34.07

1.1

u/ml

—

(3004588) Protein electrophoresis panel - Serum or Plasma

348

1745

2.10

33.86

1.7

1.8

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

7.06

33.81

1.8

2.3

e9/l

0.2

0.38

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

333

1645

2.13

33.69

1.8

1.4

—

(3003338) MCHC [Mass/volume]

1575

19395

0.65

33.15

49.1

17.5

g/l

323.7

332.3

143.39

1541

19178

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

156

555

2.89

32.15

5.6

3.5

mg/l

2.1

1.6

5.97

139

495

(3033658) Prothrombin time (PT) actual/Normal

865

5843

1.64

31.82

7.9

3.4

81.8

84.3

1.81

839

5699

(3018095) Leukocytes [#/volume] in Urine

1204

8799

1.57

31.82

6.1

3.5

e6/l

162.4

126.4

0.40

977

6288

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1952

22901

0.65

31.79

7.8

6.2

mmol/mol

44.8

40.4

45.68

1730

20695

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

191

4.31

31.34

2.8

2.4

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1965

16051

1.53

30.66

7.4

4.3

e6/l

285.4

2070.8

3.25

271

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

247

3.84

30.65

1.4

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

107

315

3.47

30.29

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

223

3.97

30.13

1.4

1.3

u/ml

308.8

283.0

0.32

131

(3019309) Folate [Moles/volume] in Red Blood Cells

819

5544

1.62

29.54

2.1

1.8

nmol/l

1221.1

1161.3

0.83

588

4106

(3044242) Glucose [Moles/volume] in Arterial blood

117

5.19

29.18

2.2

1.5

—

(40758558) Short blood count panel - Blood

801

5414

1.62

28.99

10.0

5.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

339

1779

2.00

28.99

4.1

3.5

ng/l

111.8

94.4

2.19

270

1510

(3007164) IgA [Mass/volume] in Serum or Plasma

547

3376

1.74

27.89

1.8

1.4

g/l

2.9

2.6

1.67

367

1877

(3004119) Hemoglobin [Mass/volume] in Venous blood

309

1595

2.03

27.64

5.5

3.0

g/l

131.7

128.1

1.79

290

1552

(3003181) Sodium [Moles/volume] in Urine

115

378

3.11

27.26

1.8

1.4

mmol/l

66.5

62.0

0.42

308

(3010813) Leukocytes [#/volume] in Blood

2387

26588

0.65

26.81

53.5

19.4

e9/l

8.3

6.7

131.16

2292

25470

(3004809) Band form neutrophils/100 leukocytes in Blood

103

321

3.27

26.67

4.1

3.5

1.3

1.5

0.31

228

(3000963) Hemoglobin [Mass/volume] in Blood

2389

26592

0.65

26.52

54.0

19.5

g/l

131.6

134.7

14.42

2323

26006

(3026361) Erythrocytes [#/volume] in Blood

2389

26586

0.65

26.40

53.3

19.4

e12/l

4.5

4.4

1.26

2295

25470

(3035941) MCH [Entitic mass]

2389

26585

0.65

26.38

53.1

19.3

29.8

30.5

45.11

2324

25982

(3024731) MCV [Entitic volume]

2389

26584

0.65

26.36

53.2

19.3

92.1

91.6

3.52

2325

25980

(3007461) Platelets [#/volume] in Blood

2389

26575

0.65

26.17

53.4

19.4

e9/l

248.4

235.7

14.34

2306

25574

(3051651) Icteric interference index of Serum or Plasma

102

5.25

26.17

3.8

3.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

208

940

2.29

26.11

1.4

1.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2291

25665

0.66

25.43

16.8

9.4

u/l

24.8

25.3

0.43

2214

24315

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

110

374

3.00

24.62

2.1

1.6

—

(3045716) Anion gap in Serum or Plasma

101

5.10

24.40

3.0

1.8

mmol/l

8.1

10.3

3.09

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

5.46

23.75

1.2

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

138

540

2.62

23.72

1.2

u/ml

0.3

1.0

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

230

3.53

23.53

1.0

1.1

g/l

1.6

1.5

0.77

201

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

9.38

23.47

1.3

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

7.28

23.25

1.4

ug/l

0.3

0.5

0.82

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

456

6999

0.60

22.87

2.5

3.3

ug/l

0.7

0.9

4.41

306

5067

(3014891) Appearance of Pleural fluid

15.44

22.75

1.7

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

40.28

22.63

1.4

1.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

576

3813

1.61

22.02

30.1

27.7

inr

1.7

1.4

2.55

571

(3043409) Potassium [Moles/volume] in Arterial blood

160

695

2.36

22.02

10.1

3.4

mmol/l

4.1

3.9

2.31

140

650

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

5.50

21.88

2.0

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

240

1230

2.02

21.81

7.8

3.6

48.1

45.8

0.78

231

1210

(3052851) Hemolysis interference index of Serum or Plasma

151

642

2.41

21.80

4.4

3.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

944

12271

0.68

21.73

3.9

5.6

ug/l

2.8

5.3

2.77

766

10881

(3023520) Reticulocytes [#/volume] in Blood

402

2439

1.73

21.45

3.3

2.3

e9/l

77.4

65.9

7.46

314

1852

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

8.28

21.33

1.3

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

597

4020

1.58

21.17

4.2

2.9

e6/l

2.7

1.9

1.39

379

2281

(3014271) Vancomycin [Susceptibility]

133

4.18

20.67

3.9

2.6

—

(3021589) Normoblasts [#/volume] in Blood

1277

10093

1.42

20.34

20.4

8.4

e9/l

0.0

1.00

1073

8231

(3026493) Urate [Moles/volume] in Serum or Plasma

850

6233

1.48

20.17

5.2

2.5

umol/l

3497.7

7410.9

1.81

743

5278

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

132

4.13

20.02

1.5

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1182

9240

1.42

19.92

3.9

2.6

ug/l

145.7

145.2

0.02

1073

8325

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

103

382

2.74

19.71

5.0

2.5

—

(3037756) Immunofixation for Serum or Plasma

124

505

2.51

19.66

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

135

4.04

19.43

1.5

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

431

6457

0.62

18.98

1.8

1.6

mmol/l

1.6

1.3

7.14

367

5297

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

309

1806

1.78

18.71

1.6

1.7

1.6

1.5

1.90

251

1538

(3004451) EKG impression Narrative

101

4.49

18.62

1.4

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1233

0.19

18.54

1.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

206

3.34

18.51

3.2

3.5

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

14.20

18.44

1.2

1.5

u/l

106.2

3110.6

—

(1761868) Lipid panel - Serum or Plasma

501

7203

0.64

18.25

3.1

3.2

—

(3028433) Virus identified in Specimen by Culture

7.46

18.18

1.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2151

18772

1.39

18.17

11.6

6.2

u/l

83.2

81.3

0.76

2068

17367

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

163

3.60

17.72

1.4

1.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

5.75

17.52

1.0

1.1

98.8

90.8

0.61

(21494755) Public health laboratory ask at order entry panel

979

0.13

17.08

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.44

16.76

1.5

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

102

4.25

16.62

1.0

1.1

nmol/l

0.3

25.6

1.09

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

103

419

2.50

16.42

1.1

1.2

u/l

64.7

25.8

1.28

361

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

5.19

16.21

1.2

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

7.89

16.11

1.7

2.0

e6/l

185.5

250.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

262

2.90

16.10

1.1

1.2

miu/ml

119.0

215.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

4.66

16.04

1.8

2.0

e6/l

687.4

674.9

0.03

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

155

760

2.08

15.90

2.2

2.3

ratio

3.3

3.1

0.03

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.33

15.87

1.5

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

124

558

2.26

15.78

2.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

8.36

15.34

1.3

1.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

367

2368

1.61

15.28

2.8

2.2

ug/l

9.6

7.2

1.46

300

2030

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

107

460

2.36

15.15

2.5

1.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

157

792

2.03

14.93

2.3

mg/l

53.7

57.5

0.21

110

652

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

120

3.78

14.88

1.1

titre

275.0

214.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

156

789

2.02

14.73

2.3

mg/l

44.6

54.7

0.36

108

652

(3037467) Urinalysis macro (dipstick) panel - Urine

1912

16651

1.33

14.72

7.0

4.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

237

2.86

14.10

5.3

3.9

umol/l

345.9

343.4

0.05

185

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2049

22688

0.75

14.04

34.9

12.9

ml/min/173m2

75.1

73.1

2.29

1789

18440

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

4.94

13.99

2.3

2.8

39.2

34.3

0.43

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

207

1171

1.81

13.96

5.6

2.4

0.6

0.7

0.90

202

1114

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

427

2.35

13.94

1.4

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

160

3.28

13.89

1.8

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

4.29

13.78

1.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

8.97

13.74

1.5

1.4

mmol/l

0.6

5.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

792

0.14

13.67

1.6

1.5

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

6.49

13.60

1.3

1.1

ug/l

20.0

275.4

0.50

(3041918) Cholesterol [Moles/volume] in Pleural fluid

7.62

13.52

1.3

mmol/l

1.1

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

169

908

1.90

13.42

1.6

g/l

9.3

10.2

2.29

135

745

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

177

969

1.87

13.27

1.6

g/l

3.7

3.8

0.62

121

667

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

177

970

1.87

13.22

1.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

177

971

1.86

13.18

1.6

g/l

7.7

7.3

1.57

121

695

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

5.46

13.01

1.1

1.5

76.1

76.4

0.01

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.52

13.01

4.6

1.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.52

13.01

4.6

1.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

6.13

12.89

1.6

3.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

391

2.33

12.50

1.4

1.2

u/ml

4.5

7.7

0.44

(3004616) Nuclear Ab [Presence] in Serum

209

2.85

12.42

1.6

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

298

1923

1.60

12.35

2.6

2.3

u/l

30.6

65.2

0.77

251

1620

(3013512) EKG study

982

7914

1.34

12.32

6.2

3.9

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

414

2.28

12.22

1.4

1.2

u/ml

54.7

47.7

—

(3008295) Osmolality of Serum or Plasma

218

2.78

12.07

1.7

1.2

mosm/kgh2o

276.3

280.5

0.53

158

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

4.05

12.06

1.1

1.2

ratio

1.1

0.24

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

385

2.32

12.04

1.4

1.2

u/ml

18.7

2.5

0.49

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

3.87

12.03

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

3.87

12.03

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

3.87

12.03

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

163

898

1.85

12.00

1.7

1.6

g/l

3.3

3.0

3.05

120

688

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

324

2.44

11.99

1.4

1.2

u/ml

17.6

2.6

0.48

(40761511) CBC panel - Blood by Automated count

2280

24694

0.76

11.88

37.3

12.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

249

2.64

11.81

1.4

1.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

3.78

11.68

1.1

—

(3012565) Volume of 24 hour Urine

3.78

11.68

2.4

1204.6

2023.0

6.51

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

3.78

11.68

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

3.78

11.68

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

251

2.62

11.63

1.4

1.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2384

25644

0.76

11.62

49.5

15.7

mmol/l

4.0

4.98

2306

24801

(3005988) Vibrio sp identified in Specimen by Organism specific culture

252

2.60

11.54

1.4

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

424

3005

1.47

11.36

1.3

1.2

iu/ml

28.7

34.0

0.53

141

896

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

201

1198

1.72

11.35

1.6

1.5

g/l

1.7

1.5

2.06

170

1012

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

3.86

11.32

1.3

1.4

u/l

10.9

7.5

0.29

(3015377) Calcium [Moles/volume] in Serum or Plasma

1028

8420

1.31

11.31

3.9

2.9

mmol/l

2.3

2.4

4.41

867

7123

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

429

2.20

11.24

1.6

iu/ml

0.5

0.9

0.30

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

3.81

11.15

1.0

—

(44806071)

8.76

11.09

1.0

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

5.02

10.95

1.1

1.2

82.4

80.2

0.08

(3037121) Protein [Mass/volume] in Urine

148

815

1.85

10.93

2.9

2.8

g/l

0.3

0.26

316

(3019550) Sodium [Moles/volume] in Serum or Plasma

2384

25587

0.76

10.91

49.5

15.6

mmol/l

139.3

139.8

13.98

2311

24775

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

148

818

1.84

10.81

1.6

1.7

g/l

0.5

1.1

1.73

119

674

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

173

1004

1.76

10.75

2.8

3.2

pmol/l

4.1

4.4

4.54

150

862

(21494814) CD8 cells/100 lymphocytes in Specimen

4.91

10.69

1.5

2.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

205

2.71

10.58

3.9

3.2

65.7

56.2

2.17

115

(3025941) Bacteria identified in Stool by Culture

171

994

1.75

10.57

1.3

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

258

2.50

10.53

1.4

1.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1138

9520

1.29

10.51

3.0

2.1

nmol/l

77.4

79.4

1.36

990

8288

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

253

2.51

10.45

1.4

1.3

—

(3016038) Potassium [Moles/volume] in Urine

136

3.11

10.40

2.2

1.3

mmol/l

25.0

36.6

3.59

120

(3024522) Salmonella sp identified in Specimen by Organism specific culture

254

2.50

10.36

1.4

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

121

3.24

10.35

2.7

2.4

—

(3019225) pH of Specimen

372

2629

1.46

10.08

5.8

3.7

—

(3044927) Protein electrophoresis panel - Urine

270

2.43

10.05

1.2

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.96

9.99

1.1

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

122

654

1.89

9.83

1.4

1.6

g/l

0.0

0.79

107

581

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

255

2.45

9.80

1.1

1.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

136

756

1.83

9.78

1.4

1.6

g/l

36.3

38.0

2.44

112

615

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

120

642

1.90

9.73

1.4

1.6

g/l

0.0

0.00

107

580

(3051611) Lipemic interference index of Serum or Plasma

232

2.52

9.72

4.0

3.1

—

(40768797) Stomach Pathology biopsy report

414

3014

1.42

9.55

1.3

1.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

5.01

9.53

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

5.01

9.53

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

5.01

9.53

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

5.01

9.53

1.2

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

6.17

9.43

1.3

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

127

703

1.83

9.28

1.3

1.6

g/l

0.0

0.78

111

625

(3016650) Hepatitis A virus Ab [Presence] in Serum

245

2.43

9.16

1.1

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

4.77

9.03

1.7

1.6

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

24.01

8.89

1.5

1.2

mg/l

8.9

5.7

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

3.31

8.85

8.0

5.4

mg/l

74.2

61.7

0.47

(3035637) Corticotropin [Mass/volume] in Plasma

201

2.56

8.84

1.6

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

413

0.19

8.69

1.3

1.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.12

8.68

1.2

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

125

2.98

8.57

1.1

1.0

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1998

21682

0.80

8.48

5.2

4.4

mu/l

2.0

2.1

1.05

1789

19232

(3025549) Creatine [Moles/time] in 24 hour Urine

8.47

8.44

1.3

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

242

3499

0.67

8.40

11.5

6.9

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

106

3.13

8.33

1.0

1.1

mg/l

115.9

46.5

0.51

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

4.88

8.33

1.8

2.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.98

8.30

1.1

1.5

umol/l

145.0

159.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

555

4347

1.33

8.06

4.1

2.7

e6/l

1.1

1.2

0.14

347

2576

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

109

603

1.83

8.03

1.5

1.4

—

(3021788) Differential panel - Synovial fluid

372

2.06

8.00

1.4

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1525

13500

1.23

7.99

4.5

2.9

u/l

62.0

51.0

5.04

1395

12178

(3020191) Ethanol [Moles/volume] in Serum or Plasma

125

2.89

7.97

1.4

1.3

promille

1.1

1.0

0.14

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

3.14

7.92

1.0

1.1

mg/l

588.8

311.3

0.55

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

126

2.87

7.86

1.1

—

(3017732) Neutrophils [#/volume] in Blood

210

1390

1.54

7.83

4.0

3.1

e9/l

5.3

4.1

5.37

136

990

(4027681)

3.58

7.82

1.3

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

540

0.22

7.74

1.2

1.7

—

(3044290) Cell count panel - Cerebral spinal fluid

350

2.08

7.73

1.5

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

723

5899

1.28

7.72

1.8

1.7

pmol/l

450.0

20491005.0

3.29

573

4729

(3019832) Treponema pallidum Ab [Presence] in Serum

112

634

1.79

7.67

1.5

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

130

2115

0.60

7.66

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

4.73

7.61

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

3.11

7.52

3.2

2.2

—

(3017704) Immunofixation for Urine

113

2.93

7.50

1.8

1.4

—

(3044889) 12 lead EKG panel

1605

17705

0.82

7.47

6.4

4.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

4.86

7.38

1.1

1.2

66.6

77.9

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

106

599

1.79

7.31

1.3

—

(3019150) Specific gravity of Urine by Refractometry

412

5315

0.74

7.29

5.1

4.1

kg/l

1.0

1.71

109

800

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

253

2.23

7.25

1.6

1.5

51.9

63.4

1.07

156

(3011648) Oxygen content in Venous blood

167

2.53

7.21

2.7

3.7

10.8

11.0

0.08

167

(3016750) Collection duration of Urine

144

2.65

7.19

1.7

1.9

min

501.9

498.4

0.06

101

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

281

2.15

7.12

1.3

1.2

u/ml

53.6

46.9

0.14

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

7.70

7.10

2.7

12.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

735

6070

1.27

7.04

5.7

3.3

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1901

17347

1.21

6.96

6.8

3.5

mm/h

19.3

12.5

42.87

1772

15643

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

262

2.15

6.69

1.1

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

5.72

6.56

2.3

1.6

—

(3002256) Pathology report gross observation

239

3302

0.70

6.46

1.3

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

14.29

6.38

2.3

6.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

198

2.29

6.25

1.2

1.1

u/l

176.3

69.9

0.43

123

(3039162) Centromere protein B Ab [Units/volume] in Serum

181

2.33

6.12

1.4

1.2

u/ml

56.8

33.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

494

1.78

5.98

1.1

1.2

titre

320.0

86.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

6.25

5.94

1.6

3.6

—

(40768800) Prostate Pathology biopsy report

846

0.45

5.93

1.1

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

153

2.43

5.91

1.1

1.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

15.00

5.89

3.1

3.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

205

2.21

5.78

2.4

1.8

—

0.9

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

390

1.86

5.77

1.3

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

226

2.14

5.69

1.4

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

104

631

1.67

5.66

1.4

ug/g

287.3

277.5

0.18

375

(3003694) ABO and Rh group [Type] in Blood

508

6178

0.79

5.61

1.4

1.3

—

(3024869) Neuronal Ab [Presence] in Serum

3.81

5.51

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1200

10648

1.19

5.49

3.5

2.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

105

2.67

5.47

1.1

u/l

96.7

84.1

0.30

(3020491) Glucose [Moles/volume] in Blood

159

2.34

5.46

5.8

2.4

mmol/l

7.5

7.0

0.48

104

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

352

2731

1.32

5.42

2.6

4.1

ug/l

24.4

20.9

0.09

288

2263

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

106

2.65

5.38

1.1

u/l

23.8

29.5

0.23

(3044640) Blood type and Crossmatch panel - Blood

886

7658

1.21

5.37

3.5

2.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

131

2.45

5.26

4.0

1.5

—

74.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

375

1.83

5.19

5.0

1.9

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

3.13

5.16

3.1

9.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

157

2.30

5.16

1.5

1.6

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

459

1.73

5.07

1.5

1.3

mg/l

467.5

527.1

1.12

433

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

4.20

5.07

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

325

1.86

4.87

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

391

1.78

4.84

1.5

1.3

mmol/l

4.1

3.8

1.35

366

(4198724)

3.79

4.79

2.7

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.16

4.74

3.2

9.9

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

237

1.99

4.71

1.4

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

2.95

4.69

1.0

u/l

1.0

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

14.00

4.57

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

4.40

4.54

2.1

1.7

—

(3002385) Erythrocyte distribution width [Ratio]

1793

19163

0.86

4.53

46.2

15.9

15.1

13.7

146.38

1758

18600

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.81

4.53

2.0

3.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

522

1.64

4.49

1.6

1.5

e6/l

12439.1

13526.6

0.12

373

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

148

2.24

4.47

1.7

1.8

u/field

2.5

1.2

0.38

(3006653) Thiamine [Moles/volume] in Blood

2.59

4.45

1.2

1.1

nmol/l

150.6

134.4

0.70

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

155

2.20

4.44

1.0

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.77

4.43

1.5

2.3

e6/l

37394.0

7982.9

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

307

1.83

4.41

1.7

1.5

u/l

10.2

9.2

0.28

246

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

446

1.67

4.22

1.3

—

(3044941) Cell count panel - Synovial fluid

334

1.78

4.20

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

199

2.02

4.20

1.5

1.4

41.4

23.0

1.75

124

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

3.61

4.19

1.5

1.2

pmol/l

275.9

281.7

—

(3004775) Volume in Urine collected for unspecified duration

227

1.95

4.18

1.9

2.0

500.6

621.1

1.52

132

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.42

4.17

1.1

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.35

4.07

1.3

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

157

2146

0.72

4.03

1.5

—

(3011288) Drugs identified in Urine by Screen method

144

2.16

3.90

4.5

2.3

—

(3033799) Differential panel - Peritoneal fluid

2.72

3.90

1.9

1.8

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.17

3.87

6.3

5.7

mmol/l

4.5

5.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

107

2.34

3.81

1.2

nmol/l

1.6

1.1

1.16

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

315

1.75

3.80

2.1

1.9

mg/l

24.9

36.4

0.98

(3013336) Amino acids [Identifier] in Serum or Plasma

11.99

3.76

1.7

2.0

—

(3005570) Glucose [Moles/volume] in Urine

251

1.84

3.73

2.5

1.8

—

(4094501)

609

0.50

3.69

1.1

—

(3024263) Appearance of Synovial fluid

115

2.27

3.69

1.5

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

255

1.81

3.56

1.2

—

(40768446) Kidney Pathology biopsy report

3.05

3.51

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

316

1.72

3.49

1.2

1.3

—

(3044007) Cell count panel - Peritoneal fluid

2.70

3.47

2.1

1.9

—

(4133840)

3.33

3.46

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

230

1.83

3.39

1.4

1.3

nmol/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.57

3.36

1.8

1.6

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

260

1.78

3.36

1.5

1.3

nmol/l

0.7

0.83

252

(40761535) Cells panel - Urine sediment

169

2213

0.75

3.32

3.7

3.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

481

5582

0.84

3.25

4.1

3.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.34

3.22

3.5

3.0

—

(4034850)

806

0.60

3.19

23.9

11.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

404

1.59

3.13

1.4

1.8

iu/l

3.6

5.2

0.78

134

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

152

1992

0.75

3.03

3.6

2.6

ml/min/173m2

56.8

61.2

0.24

838

(40768804) Tissue Pathology biopsy report

846

9345

0.87

3.01

2.4

2.2

—

(3016879) Cocaine [Presence] in Urine

212

1.80

2.94

3.3

1.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

402

0.47

2.88

1.3

—

(3044009) aPTT.lupus sensitive (LA screen)

5.38

2.86

1.3

1.2

—

(4035726)

243

1960

1.26

2.85

1.5

1.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.25

2.85

1.9

2.5

e6/l

493.8

587.2

0.25

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

297

1.66

2.84

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

401

1.55

2.77

1.7

1.5

e6/l

1077.2

1036.2

0.02

323

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

401

1.55

2.77

1.7

1.5

e6/l

6.0

10.8

0.56

308

(40768443) Skin Pathology biopsy report

137

1032

1.34

2.72

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

145

1880

0.76

2.70

2.9

2.0

nmol/l

11.4

11.6

0.10

125

1642

(3019174) dRVVT (LA screen)

6.00

2.69

1.2

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

896

0.66

2.61

1.4

1.3

—

(3011985) Renin [Units/volume] in Plasma

266

1.66

2.61

1.3

mu/l

69.2

67.9

0.02

230

(3000093) Morphology [Interpretation] in Blood Narrative

221

1.72

2.59

1.2

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.66

2.59

1.1

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

303

0.43

2.57

1.5

1.4

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

7.13

2.54

1.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

7.13

2.54

1.0

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

114

2.02

2.54

1.1

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

114

2.02

2.54

1.1

1.4

—

(3050794) Legionella sp Ab [Presence] in Serum

5.45

2.54

1.2

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

231

1.69

2.50

3.6

1.8

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.37

2.47

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.67

2.44

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

2.14

2.43

1.3

1.6

umol/l

18.4

23.0

0.35

(3051593) INR in Capillary blood by Coagulation assay

152

1.85

2.41

6.3

15.9

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

5.00

2.40

1.5

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

124

1.94

2.38

1.3

1.4

u/l

7.2

6.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

1996

20775

0.90

2.37

40.4

14.4

38.5

38.9

0.68

1096

13007

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

549

1.43

2.37

1.3

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

550

1.43

2.35

1.3

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

2.14

2.33

1.2

2.3

umol/l

10.9

20.2

0.57

(3045142) Bone marrow Pathology biopsy report

252

1.63

2.31

1.1

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

552

1.42

2.30

1.3

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

140

1.86

2.30

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

108

1419

0.75

2.26

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

3.48

2.26

2.1

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

714

0.65

2.26

2.0

1.6

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

3.89

2.24

1.0

1.4

mmol/l

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.89

2.24

1.1

2.1

umol/l

7.5

20.5

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

3.89

2.24

1.0

1.4

mmol/l

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.89

2.24

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.02

2.24

2.5

1.7

—

(3027008) Opiates [Presence] in Urine

232

1.64

2.21

3.6

1.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

2.33

2.20

2.1

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.33

2.17

1.0

1.1

—

(3028300) Cannabinoids [Presence] in Urine

234

1.63

2.15

3.8

1.8

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

166

1.75

2.13

1.1

—

7.9

—

(3000012) Reticulocyte production index

189

1.70

2.12

1.4

—

(3023410) Appearance of Cerebral spinal fluid

174

1.73

2.11

2.1

1.8

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.05

2.10

1.9

1.8

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

5.00

2.06

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

5.00

2.06

1.0

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

2.06

0.0

1.6

—

(3009508) Creatinine [Moles/volume] in Urine

917

8452

1.11

2.06

3.5

3.1

mmol/l

6.8

7.4

3.49

741

7017

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.50

2.05

1.4

1.8

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

3.50

2.05

1.6

1.2

u/l

13.6

7.9

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

4.00

2.03

1.7

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

695

1.34

2.02

2.5

2.1

ug/min

209.5

70.9

0.80

382

(3011335) Digoxin [Mass/volume] in Serum or Plasma

3.08

2.01

3.1

2.3

—

(3029937) Albumin [Presence] in Urine by Test strip

713

6491

1.12

1.99

5.5

3.9

estimate

0.0

0.69

357

1964

(3010144) Erythrocytes [#/volume] in Synovial fluid

201

1.64

1.97

1.4

1.2

e6/l

159116.4

91837.9

0.18

146

(36660697) Celiac disease serology panel - Serum

175

1426

1.24

1.96

1.1

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.33

1.96

1.9

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.33

1.96

1.3

1.0

—

(3016018) Differential panel - Cerebral spinal fluid

194

1.65

1.94

2.1

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.35

1.94

1.1

miu/ml

1618.8

1839.5

0.28

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

4.54

1.94

1.2

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

4.54

1.94

1.2

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

4.54

1.94

1.2

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

227

0.44

1.92

1.0

1.3

mmol/l

10.7

7.5

—

159

(3045414) Leukocytes [Presence] in Urine

1079

0.74

1.91

2.8

1.9

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.11

1.91

1.2

g/l

37.4

41.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

627

0.66

1.91

1.9

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.18

1.87

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.53

1.83

1.2

1.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

183

1518

1.21

1.76

3.6

2.8

e6/l

0.4

0.3

0.65

183

1486

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

640

5834

1.12

1.75

3.4

2.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

171

1410

1.22

1.75

2.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.50

1.73

2.7

2.5

u/field

0.1

0.4

—

(3012516) Albumin [Mass/volume] in Urine

892

8278

1.10

1.73

3.5

3.1

mg/l

910.1

268.5

2.19

633

5217

(40768441) Liver Pathology biopsy report

147

1.70

1.72

1.2

1.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.66

1.72

1.0

1.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.38

1.67

1.0

1.1

—

3.8

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

259

1.51

1.66

1.6

2.0

u/field

1.9

1.8

0.10

(3003888) Timothy IgE Ab [Units/volume] in Serum

104

1.83

1.66

1.1

1.0

u/ml

1.0

3.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

727

6694

1.11

1.65

1.7

1.5

nmol/l

19.5

20.3

0.43

620

5634

(3027944) Amphetamines [Presence] in Urine

229

1.53

1.61

4.0

1.8

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.50

1.59

2.5

1.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.50

1.59

1.0

1.1

—

(40768793) Breast Pathology biopsy report

423

0.63

1.58

1.4

1.3

—

(3048879) Bone marrow aspiration report

2.00

1.58

1.1

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

121

1.74

1.57

1.2

1.1

u/ml

0.4

1.1

—

(3006462) Nitrate [Presence] in Urine

121

1.74

1.57

3.5

3.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.82

1.56

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

450

4049

1.13

1.55

1.3

1.2

u/ml

1.8

0.03

1029

(3014051) Protein [Presence] in Urine by Test strip

573

0.69

1.52

3.5

2.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

0.00

1.52

0.0

4.4

—

7.7

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.85

1.50

1.0

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.85

1.50

1.2

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

185

1.57

1.50

3.3

1.7

—

(3015736) pH of Urine

964

9035

1.09

1.50

4.2

3.4

—

5.8

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

108

1.76

1.49

1.3

1.2

u/l

175.3

84.4

0.69

(3023323) Follitropin [Units/volume] in Serum or Plasma

317

1.42

1.46

1.8

1.5

iu/l

26.0

32.3

0.73

268

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.22

1.45

1.1

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.50

1.44

1.0

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.50

1.44

2.6

2.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

156

1.60

1.42

3.8

2.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

405

1.36

1.40

1.3

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.41

1.39

2.9

2.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

313

1.41

1.37

1.3

1.9

mu/l

313.0

300.7

0.09

289

(1617658) Protocol used for examination of sentinel lymph nodes

163

0.49

1.35

1.1

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

1.34

0.0

1.5

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

2.04

1.32

1.4

iu/ml

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.81

1.30

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.77

1.28

1.6

2.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

234

1.45

1.28

2.1

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.93

1.27

1.1

—

(3047189) Immunofixation for 24 hour Urine

107

1.68

1.24

1.6

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

253

1.42

1.22

1.2

1.3

pmol/l

267.4

243.8

0.15

189

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.63

1.21

1.0

1.2

—

(4211845)

132

1.59

1.19

3.5

3.6

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

205

1.46

1.18

1.4

1.6

u/ml

33.2

22.3

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.87

1.17

3.2

2.9

mmol/l

5.7

8.6

—

(4146454)

307

1.37

1.16

2.9

2.7

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

0.00

1.16

0.0

5.0

—

46.8

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.00

1.16

1.3

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

0.00

1.15

0.0

4.1

—

151.8

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

0.00

1.15

0.0

1.9

—

9.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.05

1.15

1.1

—

(44813793)

1.80

1.14

1.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1682

17335

0.94

1.13

4.2

3.6

pmol/l

15.4

15.0

7.49

1504

15272

(3000330) Specific gravity of Urine by Test strip

127

1492

0.84

1.11

5.4

3.5

—

(3008898) HLA-B27 [Presence]

422

0.71

1.10

1.0

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

336

1.34

1.10

1.1

iu/ml

20.0

53.4

0.87

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.67

1.09

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.67

1.09

1.1

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.38

1.09

1.2

1.1

—

(3002619) Bacteria identified in Specimen by Culture

1.95

1.08

1.0

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1189

11369

1.07

1.05

2.2

2.0

pmol/l

87.7

93.1

3.61

685

5912

(3020682) Albumin/Creatinine [Ratio] in Urine

928

8800

1.07

1.05

4.4

3.9

mg/mmol

19.0

9.8

2.43

629

5536

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.27

1.03

1.2

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.27

1.03

1.0

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

1.89

1.00

2.0

2.1

u/l

24.7

39.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.00

0.99

1.1

—

(3011436) Histone Ab [Units/volume] in Serum

2.00

0.99

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.00

0.99

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

248

0.64

0.98

1.6

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.74

0.95

1.0

1.1

—

(4281824)

216

1.39

0.94

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

302

1.33

0.94

1.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.22

0.93

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

277

1.34

0.92

1.0

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

463

1.25

0.91

2.4

1.6

nmol/l

1.1

0.7

2.50

390

(44806420)

103

0.48

0.89

1.8

2.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

149

1306

1.14

0.86

2.3

2.4

—

23.7

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.62

0.84

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

121

1.49

0.82

1.8

1.2

—

(21494434) Karyotype in Bone marrow

215

1.35

0.79

1.1

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.66

0.78

1.5

1.3

ug/l

8.0

9.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.62

0.77

1.1

—

(3035350) Ketones [Presence] in Urine by Test strip

1208

11652

1.05

0.77

5.3

3.6

estimate

0.0

0.00

390

2054

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

148

1.42

0.77

1.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.76

0.76

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.64

0.74

1.3

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.08

0.74

3.8

1.5

—

(3020393) Adenovirus Ag [Presence] in Stool

2.08

0.74

3.8

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

1226

11841

1.05

0.74

5.3

3.6

estimate

0.0

1.34

367

2009

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.79

0.72

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.71

0.69

4.3

9.4

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.85

0.68

3.6

1.6

nmol/l

0.2

0.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.85

0.68

1.2

1.3

—

168.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

156

0.64

0.67

1.0

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

657

0.83

0.66

1.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

111

1.44

0.65

1.4

1.3

u/l

14.8

29.5

—

(3048689) Calprotectin [Mass/mass] in Stool

223

2045

1.09

0.64

1.9

2.1

ug/g

182.0

166.1

0.22

176

1591

(3035933) Granulocytes/100 leukocytes in Blood

1.72

0.63

7.2

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

878

0.86

0.63

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.59

0.61

1.0

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

208

1.30

0.61

1.4

1.2

nmol/l

1.7

1.5

0.43

184

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.59

0.0

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.50

0.59

1.2

1.5

ug/l

15.2

8.1

0.46

(3003740) Influenza virus B Ag [Presence] in Specimen

148

1.35

0.59

1.2

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.51

0.58

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.71

0.57

1.2

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.66

0.56

1.0

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1.48

0.53

1.1

1.0

u/ml

1.4

2.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

301

2826

1.07

0.51

1.2

u/ml

33.3

11.9

0.58

1058

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

487

0.84

0.50

2.1

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

753

1.13

0.49

1.3

1.2

—

(3022621) pH of Urine by Test strip

184

1705

1.08

0.46

4.3

3.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

292

1.20

0.44

1.9

1.5

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

1.61

0.43

2.0

1.6

mu/l

522.4

338.5

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

1.61

0.43

2.0

1.6

76.2

71.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

1195

11663

1.03

0.43

7.0

4.8

estimate

0.0

0.00

378

2069

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

104

1.34

0.42

1.7

2.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

149

1.27

0.41

1.2

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.41

0.0

1.3

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.41

0.0

1.1

—

41.8

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.40

0.0

2.8

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

0.00

0.40

0.0

1.1

—

46.7

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.39

0.0

1.0

—

(3006270) Folate [Moles/volume] in Blood

251

1.19

0.38

1.3

1.2

nmol/l

285.5

327.2

0.58

193

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.36

0.35

1.3

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

111

1022

1.09

0.35

1.2

iu/ml

133.8

122.0

0.12

358

(3051387) C reactive protein [Mass/volume] in Capillary blood

585

1.11

0.33

5.4

3.0

mg/l

33.5

28.9

0.39

386

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.32

0.33

2.1

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

835

1.09

0.32

2.8

3.8

u/ml

51.5

58.7

0.22

801

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.29

0.29

2.1

1.2

—

(3045424) Erythrocytes [Presence] in Urine

385

0.88

0.27

2.0

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1.23

0.27

1.1

1.0

—

0.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.26

0.26

1.1

1.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

339

3272

1.04

0.25

4.5

4.8

32.7

33.1

0.27

246

2063

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

549

1.09

0.25

3.2

3.1

u/ml

95.6

1078.7

1.27

509

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

504

4903

1.03

0.24

3.4

2.8

mmol/l

2.5

13.01

419

4265

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.26

0.24

1.5

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.28

0.23

1.4

2.0

—

(3029075) Extractable nuclear Ab panel - Serum

1.25

0.22

1.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

890

9027

0.98

0.22

5.7

3.9

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.22

0.22

1.2

1.1

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

4.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.5

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.17

0.19

1.2

1.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.22

0.19

2.0

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

109

1.19

0.18

2.3

6.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

224

1.11

0.16

2.0

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.12

0.15

1.0

—

(4024509)

274

1.09

0.14

1.8

1.5

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.81

0.13

2.1

1.5

—

(3022145) Colonoscopy Study observation

261

2545

1.03

0.13

1.3

—

(3049717) Cytology report of Urine Cyto stain

137

1324

1.03

0.12

2.9

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

161

1.12

0.12

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

863

0.96

0.12

6.1

4.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1135

11247

1.01

0.10

5.9

3.9

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.08

0.09

2.6

2.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2366

23684

0.99

0.09

43.4

11.9

mg/l

27.1

25.2

2.59

2245

18236

(40768795) Lymph node Pathology biopsy report

196

0.92

0.09

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

734

0.96

0.09

1.1

—

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.03

0.08

1.3

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.83

0.08

1.0

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.77

0.08

1.0

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.06

0.07

1.9

2.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.02

0.07

1.1

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

0.85

0.07

5.3

2.4

—

(3025130) Human papilloma virus identified in Specimen

132

0.91

0.07

1.6

1.7

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

101

0.89

0.06

1.6

1.2

u/l

85.1

358.1

—

(1002224) Polysomnography panel

545

0.99

0.00

1.1

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

279

1.00

0.00

2.1

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

200

1992

1.00

0.00

1.4

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

509

1.00

0.00

1.7

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

977

1.00

0.00

2.4

3.1

u/ml

1352.5

675.8

0.48

837

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.0

2.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

552.6

—

(3020650) Glucose [Presence] in Urine

0.85

0.00

3.2

1.5

—

(3022689) Creatine [Moles/volume] in Urine

1.00

0.00

1.5

1.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

15.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.0

1.0

—

7.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.0

1.2

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

6.7

—

59.2

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

1.00

0.00

6.6

5.8

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.1

—

8.8

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: RESPIRATORYINSUFF – Respiratory insufficiency

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Respiratory insufficiency

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Respiratory insufficiency (RESPIRATORYINSUFF)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints